Immunosuppressive cells in cancer: mechanisms and potential therapeutic targets

Immunotherapies like the adoptive transfer of gene-engineered T cells and immune checkpoint inhibitors are novel therapeutic modalities for advanced cancers. However, some patients are refractory or resistant to these therapies, and the mechanisms underlying tumor immune resistance have not been ful...

Full description

Saved in:
Bibliographic Details
Published inJournal of hematology and oncology Vol. 15; no. 1; p. 61
Main Authors Tie, Yan, Tang, Fan, Wei, Yu-Quan, Wei, Xia-Wei
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 18.05.2022
BioMed Central
BMC
Subjects
Adoptive transfer
Angiogenesis
Antigens
Biomarkers
Bone marrow
Cancer
Cytokines
Dendritic cells
Development and progression
Gene expression
Genotype & phenotype
Health aspects
Hematology
Humans
Immune Checkpoint Inhibitors
Immunoregulation
Immunosuppressive cells
Immunosuppressive cellular cytokines
Immunotherapy
Leukocytes (neutrophilic)
Lymphocytes
Lymphocytes T
Macrophages
Medical prognosis
Metastasis
Neoplasms - drug therapy
Neutrophils
Oncology
Patients
Phenotypes
Review
T cells
T-Lymphocytes, Regulatory
Therapeutic applications
Therapeutic targets
Tumor cells
Tumor immune microenvironment
Tumor Microenvironment
Tumors
Vascular endothelial growth factor
Tumor immune microenvironment
Immunosuppressive cells
Immunosuppressive cellular cytokines
Immunotherapy
Online AccessGet full text

Cover

Abstract Immunotherapies like the adoptive transfer of gene-engineered T cells and immune checkpoint inhibitors are novel therapeutic modalities for advanced cancers. However, some patients are refractory or resistant to these therapies, and the mechanisms underlying tumor immune resistance have not been fully elucidated. Immunosuppressive cells such as myeloid-derived suppressive cells, tumor-associated macrophages, tumor-associated neutrophils, regulatory T cells (Tregs), and tumor-associated dendritic cells are critical factors correlated with immune resistance. In addition, cytokines and factors secreted by tumor cells or these immunosuppressive cells also mediate the tumor progression and immune escape of cancers. Thus, targeting these immunosuppressive cells and the related signals is the promising therapy to improve the efficacy of immunotherapies and reverse the immune resistance. However, even with certain success in preclinical studies or in some specific types of cancer, large perspectives are unknown for these immunosuppressive cells, and the related therapies have undesirable outcomes for clinical patients. In this review, we comprehensively summarized the phenotype, function, and potential therapeutic targets of these immunosuppressive cells in the tumor microenvironment.
AbstractList Immunotherapies like the adoptive transfer of gene-engineered T cells and immune checkpoint inhibitors are novel therapeutic modalities for advanced cancers. However, some patients are refractory or resistant to these therapies, and the mechanisms underlying tumor immune resistance have not been fully elucidated. Immunosuppressive cells such as myeloid-derived suppressive cells, tumor-associated macrophages, tumor-associated neutrophils, regulatory T cells (Tregs), and tumor-associated dendritic cells are critical factors correlated with immune resistance. In addition, cytokines and factors secreted by tumor cells or these immunosuppressive cells also mediate the tumor progression and immune escape of cancers. Thus, targeting these immunosuppressive cells and the related signals is the promising therapy to improve the efficacy of immunotherapies and reverse the immune resistance. However, even with certain success in preclinical studies or in some specific types of cancer, large perspectives are unknown for these immunosuppressive cells, and the related therapies have undesirable outcomes for clinical patients. In this review, we comprehensively summarized the phenotype, function, and potential therapeutic targets of these immunosuppressive cells in the tumor microenvironment.
Abstract Immunotherapies like the adoptive transfer of gene-engineered T cells and immune checkpoint inhibitors are novel therapeutic modalities for advanced cancers. However, some patients are refractory or resistant to these therapies, and the mechanisms underlying tumor immune resistance have not been fully elucidated. Immunosuppressive cells such as myeloid-derived suppressive cells, tumor-associated macrophages, tumor-associated neutrophils, regulatory T cells (Tregs), and tumor-associated dendritic cells are critical factors correlated with immune resistance. In addition, cytokines and factors secreted by tumor cells or these immunosuppressive cells also mediate the tumor progression and immune escape of cancers. Thus, targeting these immunosuppressive cells and the related signals is the promising therapy to improve the efficacy of immunotherapies and reverse the immune resistance. However, even with certain success in preclinical studies or in some specific types of cancer, large perspectives are unknown for these immunosuppressive cells, and the related therapies have undesirable outcomes for clinical patients. In this review, we comprehensively summarized the phenotype, function, and potential therapeutic targets of these immunosuppressive cells in the tumor microenvironment.
Immunotherapies like the adoptive transfer of gene-engineered T cells and immune checkpoint inhibitors are novel therapeutic modalities for advanced cancers. However, some patients are refractory or resistant to these therapies, and the mechanisms underlying tumor immune resistance have not been fully elucidated. Immunosuppressive cells such as myeloid-derived suppressive cells, tumor-associated macrophages, tumor-associated neutrophils, regulatory T cells (Tregs), and tumor-associated dendritic cells are critical factors correlated with immune resistance. In addition, cytokines and factors secreted by tumor cells or these immunosuppressive cells also mediate the tumor progression and immune escape of cancers. Thus, targeting these immunosuppressive cells and the related signals is the promising therapy to improve the efficacy of immunotherapies and reverse the immune resistance. However, even with certain success in preclinical studies or in some specific types of cancer, large perspectives are unknown for these immunosuppressive cells, and the related therapies have undesirable outcomes for clinical patients. In this review, we comprehensively summarized the phenotype, function, and potential therapeutic targets of these immunosuppressive cells in the tumor microenvironment. Keywords: Immunotherapy, Immunosuppressive cells, Tumor immune microenvironment, Immunosuppressive cellular cytokines
ArticleNumber 61
Audience Academic
Author Wei, Xia-Wei
Tang, Fan
Tie, Yan
Wei, Yu-Quan
Author_xml – sequence: 1
  givenname: Yan
  surname: Tie
  fullname: Tie, Yan
  organization: Laboratory of Aging Research and Cancer Drug Target, State Key Laboratory of Biotherapy, National Clinical Research Center for Geriatrics of West China Hospital, Sichuan University, No. 37 Guo Xue Xiang, Chengdu, 610041, China
– sequence: 2
  givenname: Fan
  surname: Tang
  fullname: Tang, Fan
  organization: Department of Orthopeadics, Orthopedic Research Institute, West China Hospital, Sichuan University, Chengdu, China
– sequence: 3
  givenname: Yu-Quan
  surname: Wei
  fullname: Wei, Yu-Quan
  organization: Laboratory of Aging Research and Cancer Drug Target, State Key Laboratory of Biotherapy, National Clinical Research Center for Geriatrics of West China Hospital, Sichuan University, No. 37 Guo Xue Xiang, Chengdu, 610041, China
– sequence: 4
  givenname: Xia-Wei
  surname: Wei
  fullname: Wei, Xia-Wei
  email: xiaweiwei@scu.edu.cn
  organization: Laboratory of Aging Research and Cancer Drug Target, State Key Laboratory of Biotherapy, National Clinical Research Center for Geriatrics of West China Hospital, Sichuan University, No. 37 Guo Xue Xiang, Chengdu, 610041, China. xiaweiwei@scu.edu.cn
BackLink https://www.ncbi.nlm.nih.gov/pubmed/35585567$$D View this record in MEDLINE/PubMed
BookMark eNptkl2L1DAUhousuB_6B7yQgiDedE3SfHohLIsfAwt7o9chTU-nGdqkJu2C_950Zl1nRHKRcPKcN8mb97I488FDUbzG6BpjyT8kXCPKKkRIhTCRpJLPigssGK-kIOTsaH1eXKa0Q4hjRdCL4rxmTDLGxUVxvxnHxYe0TFOElNwDlBaGIZXOl9Z4C_FjOYLtjXdpTKXxbTmFGfzszFDOPUQzwTI7W84mbmFOL4vnnRkSvHqcr4ofXz5_v_1W3d1_3dze3FWWKTpXsiOikwxMxxnuWooNsk3TCqbaRipBwNqGc0GUbTushKUtV01NmpozIyRl9VWxOei2wez0FN1o4i8djNP7QohbbWK-1wCaCGooFVTWTUcRCGUsx6jGCGVxBDxrfTpoTUszQmvz66IZTkRPd7zr9TY8aJW_gUmZBd4_CsTwc4E069Gl1UbjISxJE865QgJhnNG3_6C7sESfrdpTFElF1F9qa_IDnO9CPteuovpGIJoJxVfq-j9UHi2MzuasdC7XTxreHTX0YIa5T2HI_xd8OgXJAbQxpBShezIDI71mTx-yp3P29D57enXhzbGNTy1_wlb_Bhik1Rs
CitedBy_id crossref_primary_10_3390_pharmaceutics15072003
crossref_primary_10_1007_s00432_024_05777_4
crossref_primary_10_1016_j_canlet_2022_216009
crossref_primary_10_1016_j_ejmech_2022_114884
crossref_primary_10_3389_fonc_2022_958720
crossref_primary_10_1007_s10495_023_01884_8
crossref_primary_10_1007_s12033_024_01159_w
crossref_primary_10_3748_wjg_v30_i16_2195
crossref_primary_10_3389_fphar_2024_1337883
crossref_primary_10_1186_s43556_022_00109_9
crossref_primary_10_1002_smtd_202300252
crossref_primary_10_3389_fimmu_2023_1230893
crossref_primary_10_1111_apha_14164
crossref_primary_10_3390_cancers14215346
crossref_primary_10_1200_PO_23_00595
crossref_primary_10_1038_s44321_023_00022_w
crossref_primary_10_1007_s40610_023_00157_2
crossref_primary_10_1016_j_heliyon_2024_e31299
crossref_primary_10_3389_fimmu_2023_1268745
crossref_primary_10_1186_s40001_024_01711_z
crossref_primary_10_1016_j_apsb_2024_03_027
crossref_primary_10_1186_s12885_024_11961_z
crossref_primary_10_1016_j_intimp_2023_110078
crossref_primary_10_1038_s41416_023_02381_0
crossref_primary_10_1039_D3NR05470E
crossref_primary_10_1016_j_molimm_2024_01_007
crossref_primary_10_1002_adfm_202312092
crossref_primary_10_3389_fimmu_2023_1213629
crossref_primary_10_1038_s12276_023_01080_3
crossref_primary_10_3390_cells13110977
crossref_primary_10_1016_j_hbpd_2022_07_006
crossref_primary_10_1186_s13045_024_01544_7
crossref_primary_10_3390_cancers16101908
crossref_primary_10_1038_s41419_023_06053_y
crossref_primary_10_1186_s40164_023_00452_9
crossref_primary_10_1002_anbr_202300061
crossref_primary_10_1016_j_ccell_2023_08_012
crossref_primary_10_1007_s00432_023_05029_x
crossref_primary_10_1016_j_heliyon_2024_e33928
crossref_primary_10_3390_biomedicines12030697
crossref_primary_10_34133_research_0247
crossref_primary_10_3803_EnM_2023_1802
crossref_primary_10_1002_adfm_202405051
crossref_primary_10_3389_fimmu_2024_1363102
crossref_primary_10_3389_fendo_2023_1164692
crossref_primary_10_1016_j_biopha_2024_116660
crossref_primary_10_1016_j_intimp_2024_112623
crossref_primary_10_1016_j_ctrv_2023_102629
crossref_primary_10_1615_IntJMedMushrooms_2023049062
crossref_primary_10_1186_s13578_023_01073_9
crossref_primary_10_1111_imcb_12723
crossref_primary_10_2217_imt_2022_0137
crossref_primary_10_3389_fgene_2022_988703
crossref_primary_10_3390_ijms241713062
crossref_primary_10_3389_fonc_2024_1322897
crossref_primary_10_3390_diagnostics14050553
crossref_primary_10_1186_s12883_023_03236_0
crossref_primary_10_3389_fimmu_2023_1223695
crossref_primary_10_1016_j_celrep_2023_112599
crossref_primary_10_1186_s12967_024_05389_z
crossref_primary_10_3389_fimmu_2022_1096551
crossref_primary_10_1096_fj_202201022RRR
crossref_primary_10_3389_fimmu_2024_1331641
crossref_primary_10_3389_fphar_2022_1035954
crossref_primary_10_1007_s00432_023_05268_y
crossref_primary_10_3389_fimmu_2024_1344272
crossref_primary_10_1007_s12088_024_01274_x
crossref_primary_10_1016_j_biopha_2022_113998
crossref_primary_10_1038_s41392_022_01175_9
crossref_primary_10_1063_5_0195244
crossref_primary_10_1186_s12967_023_04238_9
crossref_primary_10_3390_vaccines11020394
crossref_primary_10_1038_s41416_023_02561_y
crossref_primary_10_1080_15583724_2023_2234462
crossref_primary_10_1007_s12274_023_6212_y
crossref_primary_10_3390_biology12030376
crossref_primary_10_3390_cells13131106
crossref_primary_10_1186_s40164_024_00505_7
crossref_primary_10_12677_ACM_2024_141045
crossref_primary_10_1016_j_jconrel_2023_09_050
crossref_primary_10_1016_j_bbagen_2024_130596
crossref_primary_10_20517_cdr_2023_33
crossref_primary_10_1007_s13205_024_03958_z
crossref_primary_10_3390_cancers15245857
crossref_primary_10_1016_j_eng_2022_11_006
crossref_primary_10_3389_fimmu_2023_1104711
crossref_primary_10_1016_j_clicom_2023_11_002
crossref_primary_10_3390_cancers15153861
crossref_primary_10_1002_adhm_202300688
crossref_primary_10_1080_00207454_2024_2356152
crossref_primary_10_1038_s41413_023_00246_z
crossref_primary_10_3390_pharmaceutics15041143
crossref_primary_10_1186_s12943_023_01885_w
crossref_primary_10_1016_j_phrs_2023_106995
crossref_primary_10_1080_1750743X_2024_2343271
crossref_primary_10_3389_fcell_2024_1343938
crossref_primary_10_3389_fimmu_2023_1227150
crossref_primary_10_1136_jitc_2022_006533
crossref_primary_10_1016_j_phrs_2024_107297
crossref_primary_10_1007_s10517_023_05743_z
crossref_primary_10_1002_adma_202308977
crossref_primary_10_1038_s44222_023_00148_z
crossref_primary_10_1080_15384047_2024_2308097
crossref_primary_10_3389_fonc_2022_1096717
crossref_primary_10_3390_pharmaceutics14081630
crossref_primary_10_1038_s41598_022_23359_7
crossref_primary_10_3343_alm_2023_0443
crossref_primary_10_3389_fimmu_2023_1308264
crossref_primary_10_1186_s40164_024_00532_4
crossref_primary_10_1093_jjco_hyae033
crossref_primary_10_3390_ijms241512317
crossref_primary_10_1007_s12094_024_03477_6
crossref_primary_10_1016_j_phymed_2023_155191
crossref_primary_10_1016_j_drudis_2023_103686
crossref_primary_10_3390_pharmaceutics16020260
crossref_primary_10_3390_ijms25073780
crossref_primary_10_3390_ijms241713269
crossref_primary_10_1186_s13045_023_01452_2
crossref_primary_10_1016_j_jpha_2023_04_013
crossref_primary_10_1080_2162402X_2024_2370544
crossref_primary_10_1016_j_cej_2024_148953
crossref_primary_10_1186_s40364_023_00543_z
crossref_primary_10_1016_j_actbio_2023_10_002
crossref_primary_10_1016_j_isci_2024_108833
crossref_primary_10_1039_D4BM00286E
crossref_primary_10_1016_j_scib_2024_01_025
crossref_primary_10_1038_s41598_024_60501_z
crossref_primary_10_1186_s12964_024_01633_7
crossref_primary_10_1016_j_dnarep_2023_103594
crossref_primary_10_3390_cancers16010081
crossref_primary_10_1186_s40364_023_00498_1
crossref_primary_10_1186_s40824_023_00462_y
crossref_primary_10_1097_MD_0000000000034582
crossref_primary_10_1186_s13045_023_01487_5
crossref_primary_10_1016_j_actbio_2023_05_051
crossref_primary_10_1093_nargab_lqad109
crossref_primary_10_3390_ijms24076712
crossref_primary_10_1016_j_cej_2024_150524
crossref_primary_10_1038_s41598_024_60780_6
crossref_primary_10_1515_med_2023_0886
crossref_primary_10_1002_ctm2_1346
crossref_primary_10_1002_cac2_12576
crossref_primary_10_1186_s13058_024_01815_8
crossref_primary_10_1002_advs_202307920
crossref_primary_10_1186_s12967_022_03813_w
crossref_primary_10_3390_ijms242316933
crossref_primary_10_1186_s12951_023_01975_3
crossref_primary_10_1021_jacs_3c14005
crossref_primary_10_3389_ti_2023_11552
crossref_primary_10_1007_s11684_023_1048_0
crossref_primary_10_54097_hset_v54i_9775
crossref_primary_10_1093_oncolo_oyad193
crossref_primary_10_1186_s13045_023_01430_8
crossref_primary_10_2174_1568009623666230712095021
Cites_doi 10.1016/j.pharmthera.2016.04.003
10.1136/jitc-2020-001557
10.1016/j.immuni.2019.01.020
10.1016/j.jaci.2010.05.022
10.1158/0008-5472.CAN-11-3917
10.1172/JCI97642
10.1186/s12943-020-01234-1
10.1158/0008-5472.CAN-10-3055
10.1172/JCI89455
10.1158/0008-5472.CAN-05-1734
10.1101/cshperspect.a028548
10.1073/pnas.1910856117
10.1016/j.ccell.2016.04.014
10.1158/2159-8290.CD-19-0541
10.1016/j.semcancer.2019.07.017
10.1038/s41591-019-0420-8
10.1038/cddis.2017.192
10.1016/j.semcancer.2013.02.004
10.1016/j.biomaterials.2016.04.010
10.1080/2162402X.2016.1200771
10.1158/0008-5472.CAN-19-1246
10.3389/fonc.2019.00241
10.1080/2162402X.2015.1134073
10.1084/jem.20061104
10.1200/JCO.2011.35.6295
10.1038/s41586-020-2054-x
10.1038/s41467-020-20599-x
10.1038/ncomms6997
10.1007/s12026-016-8789-7
10.1038/s41419-018-0458-4
10.1200/JCO.2016.68.1106
10.1111/imm.12910
10.1007/s10067-018-4119-x
10.1016/j.biomaterials.2020.120601
10.1158/2326-6066.CIR-15-0189
10.1038/ni1102-991
10.1158/0008-5472.CAN-18-1351
10.1172/JCI130952
10.1016/j.ccell.2017.10.005
10.1136/jitc-2019-000210
10.1158/0008-5472.CAN-09-3690
10.1111/jcmm.12003
10.1016/j.celrep.2015.08.077
10.1038/nrc.2017.110
10.1016/j.cell.2017.12.026
10.1038/s41590-017-0022-x
10.1016/j.immuni.2016.01.013
10.1158/2326-6066.CIR-18-0489
10.1158/2326-6066.CIR-15-0036
10.1182/blood-2009-08-237412
10.1158/2326-6066.CIR-19-0144
10.1007/s00018-015-2005-0
10.1016/j.celrep.2018.05.082
10.1158/2326-6066.CIR-15-0195
10.1016/j.immuni.2015.02.004
10.1038/cmi.2014.40
10.1016/j.pharmthera.2018.12.004
10.7150/thno.35434
10.1038/nm.3423
10.1038/nri1867
10.1097/JTO.0000000000000364
10.1158/0008-5472.CAN-12-2731
10.1172/JCI128672
10.1038/onc.2017.28
10.1038/s41467-021-21099-2
10.1126/scitranslmed.aan5488
10.1158/1940-6207.CAPR-11-0247
10.1172/JCI65180
10.1038/onc.2013.154
10.1016/j.jtho.2016.04.026
10.1002/hep.26790
10.1002/ijc.30538
10.1136/gutjnl-2015-310514
10.1158/0008-5472.CAN-18-3125
10.1016/j.it.2016.01.004
10.1126/science.aao4227
10.1021/acsnano.8b06699
10.1038/cr.2016.151
10.1136/gutjnl-2016-313075
10.4049/jimmunol.1201654
10.1158/2326-6066.CIR-18-0448
10.1158/1078-0432.CCR-09-3272
10.1136/jitc-2020-000826
10.1172/JCI97354
10.1053/j.gastro.2020.10.036
10.1245/s10434-020-09371-z
10.1016/j.cell.2017.08.004
10.1038/s41586-019-1215-2
10.1158/2326-6066.CIR-16-0297
10.1186/s13046-020-01546-6
10.1136/jitc-2020-001341
10.1186/s40425-019-0785-8
10.1016/j.immuni.2021.03.022
10.1002/adma.202004853
10.1016/j.semcancer.2015.03.004
10.1136/jitc-2020-000764
10.1038/s41577-020-0296-3
10.1158/1078-0432.CCR-18-0717
10.1007/s00109-019-01795-9
10.1073/pnas.2002806117
10.1016/j.bbcan.2021.188547
10.1158/2326-6066.CIR-16-0309
10.1158/1078-0432.CCR-19-2625
10.1158/0008-5472.CAN-13-1686
10.1016/j.pharmthera.2021.107986
10.1158/0008-5472.CAN-18-3962
10.1016/j.tips.2017.11.007
10.1158/0008-5472.CAN-13-3723
10.1016/j.biopha.2019.109458
10.1016/j.immuni.2004.08.010
10.1038/nm.3547
10.1084/jem.20111413
10.1158/2326-6066.CIR-13-0152
10.1007/s12272-014-0379-4
10.1038/s41586-019-1456-0
10.1172/jci.insight.126853
10.1016/j.it.2015.02.005
10.1016/j.ccell.2018.10.007
10.1016/j.biomaterials.2017.11.017
10.1007/s00262-012-1223-7
10.1016/j.celrep.2018.06.052
10.1158/2326-6066.CIR-18-0045
10.1038/s43018-020-00133-0
10.1158/0008-5472.CAN-15-3164
10.1038/ncb3371
10.1158/2326-6066.CIR-20-0638
10.1200/JCO.2016.66.9697
10.1093/annonc/mdy089
10.1158/0008-5472.CAN-07-2593
10.4049/jimmunol.176.1.191
10.1158/0008-5472.CAN-18-3604
10.1126/scitranslmed.abg8693
10.1186/s40425-018-0360-8
10.1016/j.immuni.2017.03.013
10.3390/jcm10204717
10.1186/s40425-019-0674-1
10.1084/jem.20100619
10.1158/0008-5472.CAN-10-1379
10.1016/j.biomaterials.2014.09.007
10.1016/j.lfs.2020.117925
10.1136/jitc-2019-000433
10.1002/eji.202048992
10.1038/ncomms12150
10.1158/1078-0432.CCR-18-2882
10.1158/1078-0432.CCR-18-1038
10.1038/nrd.2018.148
10.4049/jimmunol.181.7.4666
10.1158/2159-8290.CD-RW2019-123
10.1016/j.trecan.2019.10.013
10.1158/1078-0432.CCR-19-1090
10.1080/2162402X.2015.1008355
10.1158/0008-5472.CAN-04-4037
10.1038/nrc3893
10.1007/s10549-015-3508-y
10.1093/carcin/bgs123
10.4049/jimmunol.1501853
10.1038/s41590-017-0004-z
10.1084/jem.20130440
10.1038/leu.2017.21
10.1182/blood-2011-07-365825
10.1016/j.cmet.2020.10.022
10.1111/imm.13058
10.1158/2326-6066.CIR-14-0137
10.1136/gutjnl-2017-313738
10.1016/j.ebiom.2019.08.025
10.1186/s12967-016-1037-z
10.1111/imm.12888
10.1016/j.cell.2021.05.027
10.1158/1078-0432.CCR-16-0387
10.1158/2326-6066.CIR-15-0230
10.1158/0008-5472.CAN-17-0393
10.3390/cells10061510
10.1016/j.ajpath.2019.09.016
10.1186/s13045-017-0430-2
10.1016/j.semcancer.2012.12.002
10.1016/j.pharmthera.2017.11.004
10.1158/1078-0432.CCR-15-1399
10.1038/s41586-019-1118-2
10.1038/nrd.2018.97
10.1172/jci.insight.130748
10.1002/ctm2.434
10.1038/ni.2456
10.1038/nature14407
10.1016/j.immuni.2014.02.012
10.1002/ijc.31982
10.4049/jimmunol.1201325
10.1038/s41586-021-03326-4
10.1080/2162402X.2015.1072672
10.1136/jitc-2020-002242
10.1158/0008-5472.CAN-16-0797
10.1136/jitc-2020-000772
10.1158/0008-5472.CAN-21-1148
10.1038/s41467-021-20893-2
10.1038/nri3175
10.1002/ijc.32624
10.1038/s41423-018-0004-4
10.1158/0008-5472.CAN-15-1490
10.1038/s41392-021-00670-9
10.1158/2326-6066.CIR-18-0070
10.1084/jem.20171435
10.1080/2162402X.2016.1208875
10.1158/2326-6066.CIR-20-0034
10.1016/j.ccr.2013.10.009
10.1080/2162402X.2020.1777625
10.1158/1078-0432.CCR-10-1757
10.1002/path.5585
10.1080/15384047.2018.1450116
10.1016/j.cell.2018.12.040
10.1186/s40425-018-0356-4
10.1038/s41591-020-0880-x
10.1158/2326-6066.CIR-17-0537
10.1158/0008-5472.CAN-11-3110
10.1073/pnas.1721434116
10.1186/s40425-019-0706-x
10.1016/j.cell.2019.02.005
10.1080/2162402X.2016.1261779
10.1084/jem.20130056
10.1007/s10549-011-1889-0
10.1158/0008-5472.CAN-13-2800
10.1158/0008-5472.CAN-19-3670
10.1038/ncomms13720
10.1136/jitc-2021-002741
10.1158/0008-5472.CAN-12-4601
10.1158/2159-8290.CD-14-0621
10.1158/2159-8290.CD-16-0850
10.1158/1078-0432.CCR-17-0357
10.1080/2162402X.2020.1792058
10.1038/s41467-017-01385-8
10.1084/jem.20062512
10.1038/s41577-018-0046-y
10.1080/2162402X.2018.1442167
10.1136/jitc-2021-003623
10.1158/0008-5472.CAN-17-3415
10.1073/pnas.1710877114
10.1016/j.canlet.2020.07.022
10.1158/0008-5472.CAN-15-0125
10.1016/j.intimp.2018.08.007
10.1073/pnas.0601807103
10.1158/0008-5472.CAN-16-1839
10.1158/1078-0432.CCR-12-2623
10.1126/scisignal.aak9702
10.1080/2162402X.2017.1408745
10.1016/j.jtho.2016.04.015
10.7554/eLife.36688
10.1016/j.trecan.2017.06.005
10.1007/s11523-017-0525-2
10.1016/j.freeradbiomed.2012.02.007
10.1101/cshperspect.a028597
10.1038/nrd.2018.169
10.1126/sciimmunol.aba0759
10.1016/j.canlet.2019.05.003
10.1158/1078-0432.CCR-14-1711
10.1016/j.bcp.2020.114354
10.1158/2326-6066.CIR-15-0157
10.3389/fimmu.2020.01590
10.1002/hep.27665
10.1189/jlb.0311177
10.1093/annonc/mdz006
10.1016/j.immuni.2020.03.001
10.1038/nm.3337
10.1038/nature14282
10.1073/pnas.1221535110
10.1016/j.ebiom.2017.07.014
10.1186/s13045-020-00983-2
10.1038/s41416-019-0578-3
10.1158/0008-5472.CAN-20-3564
10.1038/s41571-019-0222-4
10.3389/fimmu.2012.00190
10.1021/acsnano.7b05465
10.1158/2326-6066.CIR-14-0118
10.1186/s13046-019-1357-y
10.1002/ijc.31808
10.1126/scitranslmed.aaw7843
10.1158/0008-5472.CAN-16-0144
10.1016/j.ctrv.2017.08.004
10.3389/fimmu.2020.582657
10.1038/s41568-019-0183-z
10.1186/s40425-019-0676-z
10.1158/2326-6066.CIR-18-0751
10.1038/s41423-019-0306-1
10.1016/j.intimp.2011.01.007
10.1038/s41392-021-00484-9
10.1084/jem.20181170
10.1189/jlb.4MR1116-466R
10.1038/s41467-021-22885-8
10.1158/2326-6066.CIR-18-0725
10.1016/j.ebiom.2016.02.024
10.1136/jitc-2020-000889
10.1186/s12943-017-0707-7
10.1038/s41571-019-0175-7
10.1038/nri3707
10.1158/1078-0432.CCR-14-1399
10.1158/1078-0432.CCR-20-4459
10.1111/imr.12528
10.1038/s41586-020-2850-3
10.1016/j.biotechadv.2011.06.018
10.1186/s12943-019-1110-3
10.1158/1940-6207.CAPR-14-0094
10.1038/cmi.2018.8
10.1038/srep24249
10.1016/j.ccr.2009.06.017
10.1080/2162402X.2015.1067744
10.1186/ar3736
10.1172/JCI137110
10.1038/s41392-020-0124-z
10.1038/s41573-019-0041-4
10.1038/nature12297
10.1084/jem.20191369
10.1016/j.immuni.2019.03.020
10.4049/jimmunol.1501785
10.1093/annonc/mdz163
10.1001/jamaoncol.2020.5572
10.1136/jitc-2020-002323
10.1186/s13046-020-01713-9
10.1038/nm.3560
10.1186/s40425-018-0436-5
10.1158/1078-0432.CCR-20-0558
10.1158/2326-6066.CIR-18-0578
10.1158/1078-0432.CCR-14-3145
10.1158/0008-5472.CAN-16-2913
10.3389/fimmu.2019.00704
10.1016/j.immuni.2015.04.005
10.1038/s41423-020-00613-4
10.1038/s41467-018-03080-8
10.1158/1078-0432.CCR-16-2748
10.4049/jimmunol.1202781
10.1002/ijc.29297
10.1101/cshperspect.a028530
10.1038/mt.2015.175
10.1073/pnas.1316796110
10.1016/j.molimm.2014.02.020
10.3390/cells8121647
10.1158/2159-8290.CD-21-0764
10.1126/science.1198443
10.1158/0008-5472.CAN-09-3278
10.1016/j.ymeth.2013.06.020
10.1038/s41388-018-0449-z
10.1016/j.molcel.2017.01.021
10.1038/nature13444
10.1158/2326-6066.CIR-13-0031-T
10.1016/j.biomaterials.2020.119983
10.1038/s41467-017-01062-w
10.1158/1078-0432.CCR-16-1784
10.1186/s40425-019-0570-8
10.1164/rccm.201406-1137OC
10.4049/jimmunol.1200819
10.1158/0008-5472.CAN-18-1229
10.1038/s41392-020-0115-0
10.1038/nri1498
10.1186/s13045-021-01193-0
10.1158/0008-5472.CAN-15-1524
10.1038/s41587-020-0462-y
10.1172/JCI46266
10.1080/2162402X.2016.1197458
10.1007/s00262-019-02466-x
10.1016/j.annonc.2020.07.009
10.1073/pnas.2023739118
10.1016/j.it.2016.01.002
10.1016/j.immuni.2019.03.011
10.7150/thno.25613
10.1038/ni.2526
10.1016/j.cytogfr.2016.08.002
10.1038/s41568-020-0281-y
10.1038/s41568-019-0193-x
10.1016/j.addr.2017.04.010
10.1016/j.trecan.2021.04.007
10.1158/2326-6066.CIR-14-0095
10.1016/j.ccell.2015.03.010
10.1073/pnas.1612920114
10.1038/s41565-020-00810-2
10.1038/s41388-020-01636-x
10.1038/s41590-019-0346-9
10.1084/jem.20181468
10.1038/s41577-019-0232-6
10.1002/adfm.202006220
10.1038/nri.2017.49
10.1158/1078-0432.CCR-17-0741
10.1158/1078-0432.CCR-06-0053
10.1182/blood-2008-10-183251
10.1158/0008-5472.CAN-17-0348
10.1111/sji.12580
10.1158/1078-0432.CCR-15-0357
10.1007/s00262-019-02418-5
10.3892/ijmm.2016.2679
10.1016/j.immuni.2015.05.023
ContentType Journal Article
Copyright 2022. The Author(s).
COPYRIGHT 2022 BioMed Central Ltd.
2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
The Author(s) 2022
Copyright_xml – notice: 2022. The Author(s).
– notice: COPYRIGHT 2022 BioMed Central Ltd.
– notice: 2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: The Author(s) 2022
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
3V.
7T5
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
H94
K9.
M0S
M1P
PIMPY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.1186/s13045-022-01282-8
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
ProQuest Central (Corporate)
Immunology Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni Edition)
Medical Database
Publicly Available Content Database
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Publicly Available Content Database
ProQuest Central Essentials
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Central China
ProQuest Hospital Collection (Alumni)
ProQuest Central
ProQuest Health & Medical Complete
Health Research Premium Collection
ProQuest Medical Library
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
AIDS and Cancer Research Abstracts
Immunology Abstracts
ProQuest One Academic
ProQuest Medical Library (Alumni)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList



MEDLINE
CrossRef
Publicly Available Content Database
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1756-8722
EndPage 61
ExternalDocumentID oai_doaj_org_article_274a447483bf40e79ac6103100cdf0e6
A704293969
10_1186_s13045_022_01282_8
35585567
Genre Journal Article
Review
GrantInformation_xml – fundername: the National Natural Science Foundation of China
  grantid: 82002847
– fundername: the Excellent Youth Foundation of Sichuan Scientific Committee Grant in China
  grantid: 2019JDJQ008
– fundername: the Key Programs of Sichuan Scientific Committee Grant in China
  grantid: 2020YFS0144
– fundername: the National Natural Science Foundation Regional Innovation and Development
  grantid: U19A2003
– fundername: National Major Scientific and Technological Special Project for "Significant New Drugs Development"
  grantid: 2018ZX09733001
– fundername: ;
  grantid: 2020YFS0144
– fundername: ;
  grantid: U19A2003
– fundername: ;
  grantid: 82002847
– fundername: ;
  grantid: 2018ZX09733001
– fundername: ;
  grantid: 2019JDJQ008
GroupedDBID ---
-5E
-5G
-A0
-BR
0R~
2WC
3V.
53G
5VS
7X7
88E
8FI
8FJ
AAFWJ
AAJSJ
ABDBF
ABUWG
ACGFS
ACIHN
ACPRK
ACRMQ
ADBBV
ADINQ
ADRAZ
ADUKV
AEAQA
AENEX
AFKRA
AFPKN
AHBYD
AHMBA
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C24
C6C
CCPQU
CGR
CS3
CUY
CVF
DIK
DU5
E3Z
EBD
EBLON
EBS
ECM
EIF
EMOBN
ESX
F5P
FYUFA
GROUPED_DOAJ
GX1
HMCUK
HYE
IAO
IEA
IHR
IHW
INH
INR
ITC
KQ8
M1P
M48
M~E
NPM
O5R
O5S
OK1
P2P
PGMZT
PIMPY
PQQKQ
PROAC
PSQYO
RBZ
ROL
RPM
RSV
SMD
SOJ
SV3
TR2
TUS
UKHRP
~8M
AAYXX
CITATION
AFGXO
7T5
7XB
8FK
AZQEC
DWQXO
H94
K9.
PQEST
PQUKI
PRINS
7X8
5PM
ID FETCH-LOGICAL-c594t-8f27f85eaf651fd41a0cbbd759db8972eccb66729cdf197c4d69b32b365a78453
IEDL.DBID RPM
ISSN 1756-8722
IngestDate Tue Oct 22 15:12:26 EDT 2024
Tue Sep 17 21:21:17 EDT 2024
Sat Oct 05 04:36:31 EDT 2024
Thu Oct 10 19:24:53 EDT 2024
Tue Nov 19 20:57:12 EST 2024
Tue Nov 12 22:36:08 EST 2024
Tue Aug 20 22:06:56 EDT 2024
Thu Nov 21 22:34:40 EST 2024
Wed Oct 16 00:41:31 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Tumor immune microenvironment
Immunosuppressive cells
Immunosuppressive cellular cytokines
Immunotherapy
Language English
License 2022. The Author(s).
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c594t-8f27f85eaf651fd41a0cbbd759db8972eccb66729cdf197c4d69b32b365a78453
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9118588/
PMID 35585567
PQID 2666408929
PQPubID 54946
PageCount 1
ParticipantIDs doaj_primary_oai_doaj_org_article_274a447483bf40e79ac6103100cdf0e6
pubmedcentral_primary_oai_pubmedcentral_nih_gov_9118588
proquest_miscellaneous_2666907011
proquest_journals_2666408929
gale_infotracmisc_A704293969
gale_infotracacademiconefile_A704293969
gale_healthsolutions_A704293969
crossref_primary_10_1186_s13045_022_01282_8
pubmed_primary_35585567
PublicationCentury 2000
PublicationDate 2022-05-18
PublicationDateYYYYMMDD 2022-05-18
PublicationDate_xml – month: 05
  year: 2022
  text: 2022-05-18
  day: 18
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle Journal of hematology and oncology
PublicationTitleAlternate J Hematol Oncol
PublicationYear 2022
Publisher BioMed Central Ltd
BioMed Central
BMC
Publisher_xml – name: BioMed Central Ltd
– name: BioMed Central
– name: BMC
References 1282_CR292
J Mohrherr (1282_CR135) 2019; 145
L Hollander (1282_CR210) 2016; 76
L Yang (1282_CR31) 2017; 10
M Velasco-Velázquez (1282_CR107) 2012; 72
1282_CR46
C Jin (1282_CR262) 2019; 176
J Keirsse (1282_CR69) 2017; 102
F Arce Vargas (1282_CR302) 2017; 46
JA Katakowski (1282_CR383) 2016; 24
SM Abdin (1282_CR242) 2021; 9
SH Albeituni (1282_CR168) 2016; 196
BW Labadie (1282_CR182) 2019; 25
ZG Fridlender (1282_CR43) 2009; 16
S Ahmad (1282_CR317) 2017; 77
AL Chang (1282_CR312) 2016; 76
H Qin (1282_CR96) 2014; 20
L Shen (1282_CR126) 2019; 8
TL Sumpter (1282_CR74) 2012; 189
C Li (1282_CR53) 2020; 19
AD Smith (1282_CR134) 2020; 80
J Baudhuin (1282_CR278) 2013; 110
D Muraoka (1282_CR219) 2019; 129
L Zhang (1282_CR250) 2020; 13
A Oweida (1282_CR305) 2018; 24
WL Redmond (1282_CR366) 2014; 2
S Boudewijns (1282_CR377) 2020; 69
J Vincent (1282_CR85) 2010; 70
A Naing (1282_CR326) 2018; 34
M Casanova-Acebes (1282_CR254) 2018; 215
D Laoui (1282_CR70) 2016; 7
SP Tu (1282_CR165) 2012; 5
T Lövgren (1282_CR380) 2020; 9
1282_CR64
AA Barkal (1282_CR236) 2019; 572
Y Ban (1282_CR106) 2017; 77
E Limagne (1282_CR115) 2016; 76
A Schmall (1282_CR194) 2015; 191
J Faget (1282_CR252) 2021; 9
D Rinchai (1282_CR91) 2021; 11
G Agliardi (1282_CR287) 2021; 12
KY Aguilera (1282_CR6) 2014; 74
JF Jacobs (1282_CR304) 2010; 16
KP Fabian (1282_CR355) 2021; 9
V Prima (1282_CR141) 2017; 114
ZZ Yang (1282_CR360) 2020; 26
CS Tannenbaum (1282_CR119) 2019; 7
F Li (1282_CR193) 2019; 79
Y Qian (1282_CR187) 2017; 11
X Xiang (1282_CR201) 2021; 6
SL Gaffen (1282_CR261) 2014; 14
KF Bol (1282_CR374) 2016; 22
M Elkabets (1282_CR223) 2015; 27
H Shi (1282_CR120) 2017; 140
P Wang (1282_CR286) 2017; 8
MF Tavazoie (1282_CR169) 2018; 172
S Deaglio (1282_CR329) 2007; 204
TM Nywening (1282_CR199) 2018; 67
W Zhang (1282_CR248) 2019; 121
DH Munn (1282_CR346) 2018; 78
MA Morrissey (1282_CR246) 2018; 7
Y Grinberg-Bleyer (1282_CR57) 2017; 170
MJ Reilley (1282_CR130) 2018; 6
H Zhang (1282_CR384) 2020; 245
X Zhang (1282_CR362) 2018; 24
JI Youn (1282_CR10) 2012; 91
L Cassetta (1282_CR29) 2018; 17
L Raccosta (1282_CR266) 2013; 210
1282_CR367
W Lee (1282_CR39) 2019; 216
A Rodriguez-Garcia (1282_CR244) 2021; 12
W Su (1282_CR372) 2020; 32
1282_CR381
W Kim (1282_CR22) 2021; 160
MS Sasso (1282_CR88) 2016; 96
M van Egmond (1282_CR267) 2013; 23
P Forghani (1282_CR163) 2015; 153
DV Sawant (1282_CR322) 2019; 20
P Allavena (1282_CR209) 2005; 65
AN Chamseddine (1282_CR232) 2021; 231
1282_CR379
Á Teijeira (1282_CR101) 2020; 52
R Pili (1282_CR128) 2011; 29
RP Tobin (1282_CR154) 2018; 63
A Qin (1282_CR318) 2013; 17
F Koinis (1282_CR116) 2016; 11
AR Khan (1282_CR80) 2015; 6
T Rogers (1282_CR42) 2021; 7
D Ji (1282_CR306) 2020; 8
F Hossain (1282_CR171) 2015; 3
LXR agonism depletes MDSCs to promote antitumor immunity (1282_CR170) 2018; 8
1282_CR283
Y Chen (1282_CR202) 2015; 61
IM Stromnes (1282_CR216) 2019; 7
1282_CR288
ED Tait Wojno (1282_CR285) 2019; 50
A Hashimoto (1282_CR158) 2018; 78
IH Chan (1282_CR324) 2016; 5
C D'Alterio (1282_CR253) 2012; 61
DI Gabrilovich (1282_CR23) 2017; 5
Q Liu (1282_CR251) 2016; 31
RCA Sainson (1282_CR373) 2020; 8
A Naing (1282_CR325) 2016; 34
PA Levin (1282_CR224) 2016; 11
PE Fecci (1282_CR303) 2006; 12
C Raffin (1282_CR54) 2020; 20
AM Heeren (1282_CR1) 2021; 9
TA Mace (1282_CR132) 2013; 73
S Junankar (1282_CR205) 2015; 5
SO Stead (1282_CR385) 2018; 155
M Bilusic (1282_CR104) 2019; 7
EM Shevach (1282_CR350) 2006; 6
MM Queen (1282_CR51) 2005; 65
V Bronte (1282_CR11) 2016; 7
R Kinoshita (1282_CR125) 2019; 145
MC Jenmalm (1282_CR281) 2006; 176
C Sternberg (1282_CR129) 2016; 34
S Maeda (1282_CR309) 2019; 7
O Yajuk (1282_CR276) 2021; 10
C Jungnickel (1282_CR260) 2017; 36
J Wang (1282_CR279) 2013; 14
SL Jian (1282_CR175) 2017; 8
1282_CR344
1282_CR345
E Pylaeva (1282_CR296) 2019; 144
1282_CR348
R Bao (1282_CR333) 2016; 38
G Shayan (1282_CR319) 2017; 6
V Mariotti (1282_CR183) 2021; 7
MA Moreno Ayala (1282_CR342) 2019; 157
1282_CR364
R Shi (1282_CR225) 2018; 24
S Li (1282_CR5) 2020; 587
W Yao (1282_CR198) 2017; 22
A Sharabi (1282_CR52) 2018; 17
DI Gabrilovich (1282_CR12) 2012; 12
SJ Priceman (1282_CR112) 2010; 115
PA Beavis (1282_CR339) 2017; 127
1282_CR235
1282_CR237
K Li (1282_CR84) 2021; 6
H Katoh (1282_CR97) 2013; 24
C Alfaro (1282_CR103) 2017; 60
JB Mitchem (1282_CR196) 2013; 73
R Abu-Eid (1282_CR315) 2014; 2
DS Vinay (1282_CR9) 2015; 35
MW Khan (1282_CR221) 2013; 19
M Binnewies (1282_CR299) 2019; 177
M Noval Rivas (1282_CR58) 2015; 42
GC Sim (1282_CR369) 2014; 124
HR Kim (1282_CR340) 2019; 7
GC Sim (1282_CR370) 2016; 4
M Demers (1282_CR48) 2016; 5
G Hutter (1282_CR227) 2019; 116
M Collin (1282_CR76) 2018; 154
RD Leone (1282_CR331) 2018; 6
M Marra (1282_CR207) 2012; 30
H Li (1282_CR239) 2021; 268
IX Chen (1282_CR26) 2020; 117
SC Funes (1282_CR33) 2018; 154
JA Flores-Toro (1282_CR108) 2020; 117
A Tanaka (1282_CR297) 2017; 27
Z Lu (1282_CR143) 2020; 579
R Zappasodi (1282_CR354) 2019; 25
J Sota (1282_CR121) 2018; 37
LW Treffers (1282_CR269) 2020; 8
S Chen (1282_CR358) 2015; 3
Y Cheng (1282_CR273) 2018; 9
X Wang (1282_CR226) 2020; 5
K Kurose (1282_CR308) 2015; 10
V Kumar (1282_CR110) 2017; 32
HY Kim (1282_CR32) 2014; 20
F Li (1282_CR181) 2018; 19
L Wu (1282_CR361) 2019; 7
DC Hinshaw (1282_CR17) 2019; 79
R Saleh (1282_CR61) 2019; 457
L Wang (1282_CR275) 2011; 208
DH Munn (1282_CR180) 2016; 37
AP Cardoso (1282_CR30) 2014; 33
CA Bradley (1282_CR234) 2019; 19
1282_CR320
X Ma (1282_CR49) 2015; 75
V Kalia (1282_CR66) 2015; 42
JR Conejo-Garcia (1282_CR68) 2016; 164
G Beriou (1282_CR59) 2009; 113
SB Coffelt (1282_CR259) 2015; 522
GL Beatty (1282_CR214) 2011; 331
1282_CR313
L Akkari (1282_CR192) 2020; 2
S Nagaraj (1282_CR149) 2010; 16
A Sevko (1282_CR87) 2013; 190
B Ricciuti (1282_CR184) 2019; 196
V Finisguerra (1282_CR44) 2015; 522
P Guha (1282_CR133) 2019; 38
KL Han (1282_CR328) 2013; 190
SA Oldford (1282_CR83) 2015; 63
L Corrales (1282_CR264) 2012; 189
AJ Montero (1282_CR151) 2012; 132
D Ciardiello (1282_CR290) 2020; 31
M Di Pilato (1282_CR60) 2019; 570
M Feng (1282_CR280) 2019; 19
E Scheid (1282_CR375) 2016; 4
J Zhou (1282_CR167) 2011; 11
MSJ Mangan (1282_CR122) 2018; 17
S Wang (1282_CR323) 2016; 6
K Mahiddine (1282_CR294) 2020; 130
L Sun (1282_CR99) 2019; 4
P Sinha (1282_CR123) 2008; 181
T Hartwig (1282_CR93) 2017; 65
G Qin (1282_CR176) 2018; 7
N Martin-Orozco (1282_CR368) 2010; 70
R Yang (1282_CR352) 2021; 12
H Zeng (1282_CR371) 2013; 499
C Baer (1282_CR212) 2016; 18
XY Li (1282_CR337) 2019; 9
R Spolski (1282_CR67) 2018; 18
JI Youn (1282_CR142) 2013; 14
R Saleh (1282_CR72) 2020; 65
RB Holmgaard (1282_CR291) 2018; 6
D Gabrilovich (1282_CR73) 2004; 4
C Schauer (1282_CR47) 2014; 20
R Braster (1282_CR247) 2014; 65
ME Turnis (1282_CR327) 2016; 44
S Shrestha (1282_CR295) 2016; 5
JB Wing (1282_CR55) 2019; 50
A Orillion (1282_CR145) 2017; 23
MC Apodaca (1282_CR24) 2019; 7
S Devi (1282_CR256) 2013; 210
S Jaillon (1282_CR37) 2020; 20
CM Diaz-Montero (1282_CR150) 2012; 52
K Rui (1282_CR166) 2016; 64
D Sugiyama (1282_CR311) 2013; 110
NG Ring (1282_CR271) 2017; 114
A Cifuentes-Rius (1282_CR382) 2021; 16
DM Peereboom (1282_CR117) 2019; 4
C Blattner (1282_CR105) 2018; 78
X Zhou (1282_CR229) 2021; 31
F Veglia (1282_CR15) 2018; 19
NA Carter (1282_CR81) 2012; 14
A Young (1282_CR335) 2017; 77
M Ruella (1282_CR245) 2017; 7
F Marangoni (1282_CR347) 2021; 184
ZG Fridlender (1282_CR40) 2012; 33
P Cheng (1282_CR157) 2014; 74
Y Nefedova (1282_CR152) 2007; 67
L Wu (1282_CR258) 2020; 190
R Li (1282_CR156) 2021; 81
J Lv (1282_CR206) 2020; 256
CJ Perry (1282_CR215) 2018; 215
C Tecchio (1282_CR45) 2013; 23
N Horikawa (1282_CR113) 2017; 23
W Xu (1282_CR274) 2019; 7
HM Knochelmann (1282_CR65) 2018; 15
K Kurose (1282_CR314) 2015; 21
AA Al-Khami (1282_CR173) 2016; 5
AF Schott (1282_CR102) 2017; 23
R Zappasodi (1282_CR349) 2021; 591
P Eser (1282_CR289) 2018; 184
AE Mahne (1282_CR353) 2017; 77
E Loeuillard (1282_CR36) 2020; 130
H Lind (1282_CR293) 2020; 8
Z Amoozgar (1282_CR351) 2021; 12
CA Stewart (1282_CR321) 2013; 123
ME Shaul (1282_CR38) 2019; 16
Z Niu (1282_CR249) 2021; 253
B Allard (1282_CR330) 2017; 276
F Tang (1282_CR19) 2021; 28
H Nozawa (1282_CR50) 2006; 103
S Di (1282_CR161) 2019; 9
CA Gomez-Roca (1282_CR190) 2019; 30
DT Weed (1282_CR137) 2015; 21
ME Rodríguez-Ruiz (1282_CR378) 2018; 29
E Eriksson (1282_CR86) 2016; 14
AM Kvarnhammar (1282_CR365) 2019; 7
L Rao (1282_CR231) 2020; 32
K Nakamura (1282_CR16) 2020; 17
X Peng (1282_CR188) 2019; 38
R Saleh (1282_CR300) 2020; 490
I Théate (1282_CR178) 2015; 3
RB Holmgaard (1282_CR109) 2016; 6
J Le Naour (1282_CR186) 2020; 9
AR Bresnick (1282_CR124) 2015; 15
BJ Christmas (1282_CR146) 2018; 6
S Denk (1282_CR265) 2017; 86
GA Dominguez (1282_CR92) 2017; 23
J Yang (1282_CR255) 2018; 6
LB Rivera (1282_CR114) 2015; 36
P Serafini (1282_CR136) 2006; 203
Y Togashi (1282_CR341) 2019; 16
JL Wong (1282_CR140) 2016; 4
M Klichinsky (1282_CR240) 2020; 38
M O'Keeffe (1282_CR77) 2015; 72
A Ohta (1282_CR332) 2012; 3
W Ouyang (1282_CR7) 2019; 50
F Veglia (1282_CR172) 2019; 569
R Bauer (1282_CR153) 2018; 78
M Lee (1282_CR160) 2014; 37
Y Tie (1282_CR243) 2020; 5
V Kumar (1282_CR13) 2016; 37
CB Rodell (1282_CR218) 2019; 9
N Obermajer (1282_CR138) 2011; 118
SM Pyonteck (1282_CR191) 2013; 19
AH Long (1282_CR155) 2016; 4
T Keeley (1282_CR41) 2019; 5
E Ubil (1282_CR217) 2018; 128
X Zhan (1282_CR208) 2014; 35
HI Wettersten (1282_CR211) 2019; 79
J Shang (1282_CR79) 2020; 11
N Nagarsheth (1282_CR195) 2017; 17
S Baek (1282_CR376) 2015; 12
M Fujita (1282_CR139) 2011; 71
M Massara (1282_CR282) 2018; 9
L Fultang (1282_CR95) 2019; 47
H Wang (1282_CR62) 2017; 3
N Cheng (1282_CR28) 2021; 183
X Li (1282_CR197) 2017; 66
P Pittoni (1282_CR82) 2012; 72
DM Hossain (1282_CR131) 2015; 21
A Mantovani (1282_CR272) 2021; 18
N Joller (1282_CR359) 2014; 40
M Santoni (1282_CR241) 2021; 1876
JS Ko (1282_CR89) 2010; 70
K Ali (1282_CR316) 2014; 510
RB Holmgaard (1282_CR179) 2015; 13
A Grover (1282_CR386) 2021; 11
LMR Ferreira (1282_CR298) 2019; 18
ZT Freeman (1282_CR357) 2020; 130
Y Zhu (1282_CR111) 2014; 74
JE Cheong (1282_CR185) 2018; 39
B Bockorny (1282_CR257) 2020; 26
E Peranzoni (1282_CR27) 2020; 11
YM Meng (1282_CR203) 2018; 7
G Shayan (1282_CR159) 2018; 24
AA Barkal (1282_CR238) 2018; 19
CW Steele (1282_CR98) 2016; 29
TT Wang (1282_CR277) 2017; 66
EC Rosser (1282_CR78) 2015; 42
F Dammeijer (1282_CR189) 2017; 5
A Pedroza-Gonzalez (1282_CR
References_xml – volume: 164
  start-page: 97
  year: 2016
  ident: 1282_CR68
  publication-title: Pharmacol Ther
  doi: 10.1016/j.pharmthera.2016.04.003
  contributor:
    fullname: JR Conejo-Garcia
– ident: 1282_CR364
  doi: 10.1136/jitc-2020-001557
– volume: 50
  start-page: 302
  issue: 2
  year: 2019
  ident: 1282_CR55
  publication-title: Immunity
  doi: 10.1016/j.immuni.2019.01.020
  contributor:
    fullname: JB Wing
– ident: 1282_CR367
  doi: 10.1016/j.jaci.2010.05.022
– volume: 72
  start-page: 3839
  issue: 15
  year: 2012
  ident: 1282_CR107
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-11-3917
  contributor:
    fullname: M Velasco-Velázquez
– volume: 129
  start-page: 1278
  issue: 3
  year: 2019
  ident: 1282_CR219
  publication-title: J Clin Invest
  doi: 10.1172/JCI97642
  contributor:
    fullname: D Muraoka
– volume: 19
  start-page: 116
  issue: 1
  year: 2020
  ident: 1282_CR53
  publication-title: Mol Cancer
  doi: 10.1186/s12943-020-01234-1
  contributor:
    fullname: C Li
– volume: 71
  start-page: 2664
  issue: 7
  year: 2011
  ident: 1282_CR139
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-10-3055
  contributor:
    fullname: M Fujita
– volume: 127
  start-page: 929
  issue: 3
  year: 2017
  ident: 1282_CR339
  publication-title: J Clin Invest
  doi: 10.1172/JCI89455
  contributor:
    fullname: PA Beavis
– volume: 65
  start-page: 8896
  issue: 19
  year: 2005
  ident: 1282_CR51
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-05-1734
  contributor:
    fullname: MM Queen
– ident: 1282_CR320
  doi: 10.1101/cshperspect.a028548
– volume: 117
  start-page: 1129
  issue: 2
  year: 2020
  ident: 1282_CR108
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.1910856117
  contributor:
    fullname: JA Flores-Toro
– volume: 29
  start-page: 832
  issue: 6
  year: 2016
  ident: 1282_CR98
  publication-title: Cancer Cell
  doi: 10.1016/j.ccell.2016.04.014
  contributor:
    fullname: CW Steele
– volume: 9
  start-page: 1754
  issue: 12
  year: 2019
  ident: 1282_CR337
  publication-title: Cancer Discov
  doi: 10.1158/2159-8290.CD-19-0541
  contributor:
    fullname: XY Li
– volume: 65
  start-page: 13
  year: 2020
  ident: 1282_CR72
  publication-title: Semin Cancer Biol
  doi: 10.1016/j.semcancer.2019.07.017
  contributor:
    fullname: R Saleh
– volume: 25
  start-page: 759
  issue: 5
  year: 2019
  ident: 1282_CR354
  publication-title: Nat Med
  doi: 10.1038/s41591-019-0420-8
  contributor:
    fullname: R Zappasodi
– volume: 8
  issue: 5
  year: 2017
  ident: 1282_CR175
  publication-title: Cell Death Dis
  doi: 10.1038/cddis.2017.192
  contributor:
    fullname: SL Jian
– volume: 23
  start-page: 159
  issue: 3
  year: 2013
  ident: 1282_CR45
  publication-title: Semin Cancer Biol
  doi: 10.1016/j.semcancer.2013.02.004
  contributor:
    fullname: C Tecchio
– volume: 96
  start-page: 47
  year: 2016
  ident: 1282_CR88
  publication-title: Biomaterials
  doi: 10.1016/j.biomaterials.2016.04.010
  contributor:
    fullname: MS Sasso
– volume: 5
  issue: 8
  year: 2016
  ident: 1282_CR173
  publication-title: Oncoimmunology
  doi: 10.1080/2162402X.2016.1200771
  contributor:
    fullname: AA Al-Khami
– volume: 79
  start-page: 5048
  issue: 19
  year: 2019
  ident: 1282_CR211
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-19-1246
  contributor:
    fullname: HI Wettersten
– volume: 9
  start-page: 241
  year: 2019
  ident: 1282_CR161
  publication-title: Front Oncol
  doi: 10.3389/fonc.2019.00241
  contributor:
    fullname: S Di
– volume: 5
  issue: 5
  year: 2016
  ident: 1282_CR48
  publication-title: Oncoimmunology
  doi: 10.1080/2162402X.2015.1134073
  contributor:
    fullname: M Demers
– volume: 203
  start-page: 2691
  issue: 12
  year: 2006
  ident: 1282_CR136
  publication-title: J Exp Med
  doi: 10.1084/jem.20061104
  contributor:
    fullname: P Serafini
– volume: 29
  start-page: 4022
  issue: 30
  year: 2011
  ident: 1282_CR128
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2011.35.6295
  contributor:
    fullname: R Pili
– volume: 579
  start-page: 284
  issue: 7798
  year: 2020
  ident: 1282_CR143
  publication-title: Nature
  doi: 10.1038/s41586-020-2054-x
  contributor:
    fullname: Z Lu
– volume: 12
  start-page: 444
  issue: 1
  year: 2021
  ident: 1282_CR287
  publication-title: Nat Commun
  doi: 10.1038/s41467-020-20599-x
  contributor:
    fullname: G Agliardi
– volume: 6
  start-page: 5997
  year: 2015
  ident: 1282_CR80
  publication-title: Nat Commun
  doi: 10.1038/ncomms6997
  contributor:
    fullname: AR Khan
– volume: 64
  start-page: 931
  issue: 4
  year: 2016
  ident: 1282_CR166
  publication-title: Immunol Res
  doi: 10.1007/s12026-016-8789-7
  contributor:
    fullname: K Rui
– volume: 9
  start-page: 422
  issue: 4
  year: 2018
  ident: 1282_CR273
  publication-title: Cell Death Dis
  doi: 10.1038/s41419-018-0458-4
  contributor:
    fullname: Y Cheng
– volume: 34
  start-page: 3562
  issue: 29
  year: 2016
  ident: 1282_CR325
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2016.68.1106
  contributor:
    fullname: A Naing
– volume: 154
  start-page: 186
  issue: 2
  year: 2018
  ident: 1282_CR33
  publication-title: Immunology
  doi: 10.1111/imm.12910
  contributor:
    fullname: SC Funes
– volume: 37
  start-page: 2233
  issue: 8
  year: 2018
  ident: 1282_CR121
  publication-title: Clin Rheumatol
  doi: 10.1007/s10067-018-4119-x
  contributor:
    fullname: J Sota
– volume: 268
  year: 2021
  ident: 1282_CR239
  publication-title: Biomaterials
  doi: 10.1016/j.biomaterials.2020.120601
  contributor:
    fullname: H Li
– volume: 4
  start-page: 881
  issue: 10
  year: 2016
  ident: 1282_CR375
  publication-title: Cancer Immunol Res
  doi: 10.1158/2326-6066.CIR-15-0189
  contributor:
    fullname: E Scheid
– volume: 3
  start-page: 991
  issue: 11
  year: 2002
  ident: 1282_CR3
  publication-title: Nat Immunol
  doi: 10.1038/ni1102-991
  contributor:
    fullname: GP Dunn
– volume: 78
  start-page: 5191
  issue: 18
  year: 2018
  ident: 1282_CR346
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-18-1351
  contributor:
    fullname: DH Munn
– volume: 130
  start-page: 389
  issue: 1
  year: 2020
  ident: 1282_CR294
  publication-title: J Clin Invest
  doi: 10.1172/JCI130952
  contributor:
    fullname: K Mahiddine
– volume: 32
  start-page: 654
  issue: 5
  year: 2017
  ident: 1282_CR110
  publication-title: Cancer Cell
  doi: 10.1016/j.ccell.2017.10.005
  contributor:
    fullname: V Kumar
– ident: 1282_CR288
  doi: 10.1136/jitc-2019-000210
– volume: 70
  start-page: 3052
  issue: 8
  year: 2010
  ident: 1282_CR85
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-09-3690
  contributor:
    fullname: J Vincent
– volume: 17
  start-page: 252
  issue: 2
  year: 2013
  ident: 1282_CR318
  publication-title: J Cell Mol Med
  doi: 10.1111/jcmm.12003
  contributor:
    fullname: A Qin
– volume: 13
  start-page: 412
  issue: 2
  year: 2015
  ident: 1282_CR179
  publication-title: Cell Rep
  doi: 10.1016/j.celrep.2015.08.077
  contributor:
    fullname: RB Holmgaard
– volume: 17
  start-page: 765
  issue: 12
  year: 2017
  ident: 1282_CR334
  publication-title: Nat Rev Cancer
  doi: 10.1038/nrc.2017.110
  contributor:
    fullname: D Vijayan
– volume: 172
  start-page: 825
  issue: 4
  year: 2018
  ident: 1282_CR169
  publication-title: Cell
  doi: 10.1016/j.cell.2017.12.026
  contributor:
    fullname: MF Tavazoie
– volume: 19
  start-page: 108
  issue: 2
  year: 2018
  ident: 1282_CR15
  publication-title: Nat Immunol
  doi: 10.1038/s41590-017-0022-x
  contributor:
    fullname: F Veglia
– volume: 44
  start-page: 316
  issue: 2
  year: 2016
  ident: 1282_CR327
  publication-title: Immunity
  doi: 10.1016/j.immuni.2016.01.013
  contributor:
    fullname: ME Turnis
– volume: 7
  start-page: 1497
  issue: 9
  year: 2019
  ident: 1282_CR274
  publication-title: Cancer Immunol Res
  doi: 10.1158/2326-6066.CIR-18-0489
  contributor:
    fullname: W Xu
– volume: 3
  start-page: 1236
  issue: 11
  year: 2015
  ident: 1282_CR171
  publication-title: Cancer Immunol Res
  doi: 10.1158/2326-6066.CIR-15-0036
  contributor:
    fullname: F Hossain
– volume: 115
  start-page: 1461
  issue: 7
  year: 2010
  ident: 1282_CR112
  publication-title: Blood
  doi: 10.1182/blood-2009-08-237412
  contributor:
    fullname: SJ Priceman
– volume: 8
  start-page: 120
  issue: 1
  year: 2020
  ident: 1282_CR269
  publication-title: Cancer Immunol Res
  doi: 10.1158/2326-6066.CIR-19-0144
  contributor:
    fullname: LW Treffers
– volume: 72
  start-page: 4309
  issue: 22
  year: 2015
  ident: 1282_CR77
  publication-title: Cell Mol Life Sci
  doi: 10.1007/s00018-015-2005-0
  contributor:
    fullname: M O'Keeffe
– volume: 23
  start-page: 3946
  issue: 13
  year: 2018
  ident: 1282_CR270
  publication-title: Cell Rep
  doi: 10.1016/j.celrep.2018.05.082
  contributor:
    fullname: HL Matlung
– volume: 4
  start-page: 983
  issue: 11
  year: 2016
  ident: 1282_CR370
  publication-title: Cancer Immunol Res
  doi: 10.1158/2326-6066.CIR-15-0195
  contributor:
    fullname: GC Sim
– volume: 42
  start-page: 512
  issue: 3
  year: 2015
  ident: 1282_CR58
  publication-title: Immunity
  doi: 10.1016/j.immuni.2015.02.004
  contributor:
    fullname: M Noval Rivas
– volume: 12
  start-page: 87
  issue: 1
  year: 2015
  ident: 1282_CR376
  publication-title: Cell Mol Immunol
  doi: 10.1038/cmi.2014.40
  contributor:
    fullname: S Baek
– volume: 196
  start-page: 105
  year: 2019
  ident: 1282_CR184
  publication-title: Pharmacol Ther
  doi: 10.1016/j.pharmthera.2018.12.004
  contributor:
    fullname: B Ricciuti
– volume: 9
  start-page: 8426
  issue: 26
  year: 2019
  ident: 1282_CR218
  publication-title: Theranostics
  doi: 10.7150/thno.35434
  contributor:
    fullname: CB Rodell
– volume: 20
  start-page: 54
  issue: 1
  year: 2014
  ident: 1282_CR32
  publication-title: Nat Med
  doi: 10.1038/nm.3423
  contributor:
    fullname: HY Kim
– volume: 6
  start-page: 613
  issue: 8
  year: 2006
  ident: 1282_CR350
  publication-title: Nat Rev Immunol
  doi: 10.1038/nri1867
  contributor:
    fullname: EM Shevach
– volume: 10
  start-page: 74
  issue: 1
  year: 2015
  ident: 1282_CR308
  publication-title: J Thorac Oncol
  doi: 10.1097/JTO.0000000000000364
  contributor:
    fullname: K Kurose
– volume: 73
  start-page: 1128
  issue: 3
  year: 2013
  ident: 1282_CR196
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-12-2731
  contributor:
    fullname: JB Mitchem
– volume: 130
  start-page: 1405
  issue: 3
  year: 2020
  ident: 1282_CR357
  publication-title: J Clin Invest
  doi: 10.1172/JCI128672
  contributor:
    fullname: ZT Freeman
– volume: 36
  start-page: 4182
  issue: 29
  year: 2017
  ident: 1282_CR260
  publication-title: Oncogene
  doi: 10.1038/onc.2017.28
  contributor:
    fullname: C Jungnickel
– volume: 12
  start-page: 832
  issue: 1
  year: 2021
  ident: 1282_CR352
  publication-title: Nat Commun
  doi: 10.1038/s41467-021-21099-2
  contributor:
    fullname: R Yang
– ident: 1282_CR292
  doi: 10.1126/scitranslmed.aan5488
– volume: 5
  start-page: 205
  issue: 2
  year: 2012
  ident: 1282_CR165
  publication-title: Cancer Prev Res (Phila)
  doi: 10.1158/1940-6207.CAPR-11-0247
  contributor:
    fullname: SP Tu
– volume: 123
  start-page: 4859
  issue: 11
  year: 2013
  ident: 1282_CR321
  publication-title: J Clin Invest
  doi: 10.1172/JCI65180
  contributor:
    fullname: CA Stewart
– volume: 33
  start-page: 2123
  issue: 16
  year: 2014
  ident: 1282_CR30
  publication-title: Oncogene
  doi: 10.1038/onc.2013.154
  contributor:
    fullname: AP Cardoso
– volume: 11
  start-page: 1263
  issue: 8
  year: 2016
  ident: 1282_CR116
  publication-title: J Thorac Oncol
  doi: 10.1016/j.jtho.2016.04.026
  contributor:
    fullname: F Koinis
– volume: 59
  start-page: 1435
  issue: 4
  year: 2014
  ident: 1282_CR200
  publication-title: Hepatology
  doi: 10.1002/hep.26790
  contributor:
    fullname: Y Chen
– volume: 140
  start-page: 1370
  issue: 6
  year: 2017
  ident: 1282_CR120
  publication-title: Int J Cancer
  doi: 10.1002/ijc.30538
  contributor:
    fullname: H Shi
– volume: 66
  start-page: 157
  issue: 1
  year: 2017
  ident: 1282_CR197
  publication-title: Gut
  doi: 10.1136/gutjnl-2015-310514
  contributor:
    fullname: X Li
– volume: 79
  start-page: 2697
  issue: 10
  year: 2019
  ident: 1282_CR228
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-18-3125
  contributor:
    fullname: D Ma
– volume: 37
  start-page: 208
  issue: 3
  year: 2016
  ident: 1282_CR13
  publication-title: Trends Immunol
  doi: 10.1016/j.it.2016.01.004
  contributor:
    fullname: V Kumar
– ident: 1282_CR46
  doi: 10.1126/science.aao4227
– volume: 12
  start-page: 11541
  issue: 11
  year: 2018
  ident: 1282_CR204
  publication-title: ACS Nano
  doi: 10.1021/acsnano.8b06699
  contributor:
    fullname: L Tian
– volume: 27
  start-page: 109
  issue: 1
  year: 2017
  ident: 1282_CR297
  publication-title: Cell Res
  doi: 10.1038/cr.2016.151
  contributor:
    fullname: A Tanaka
– volume: 66
  start-page: 1900
  issue: 11
  year: 2017
  ident: 1282_CR277
  publication-title: Gut
  doi: 10.1136/gutjnl-2016-313075
  contributor:
    fullname: TT Wang
– volume: 189
  start-page: 4674
  issue: 9
  year: 2012
  ident: 1282_CR264
  publication-title: J Immunol
  doi: 10.4049/jimmunol.1201654
  contributor:
    fullname: L Corrales
– volume: 7
  start-page: 977
  issue: 6
  year: 2019
  ident: 1282_CR216
  publication-title: Cancer Immunol Res
  doi: 10.1158/2326-6066.CIR-18-0448
  contributor:
    fullname: IM Stromnes
– volume: 16
  start-page: 1812
  issue: 6
  year: 2010
  ident: 1282_CR149
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-09-3272
  contributor:
    fullname: S Nagaraj
– volume: 8
  issue: 2
  year: 2020
  ident: 1282_CR306
  publication-title: J Immunother Cancer.
  doi: 10.1136/jitc-2020-000826
  contributor:
    fullname: D Ji
– volume: 128
  start-page: 2356
  issue: 6
  year: 2018
  ident: 1282_CR217
  publication-title: J Clin Invest
  doi: 10.1172/JCI97354
  contributor:
    fullname: E Ubil
– volume: 160
  start-page: 781
  issue: 3
  year: 2021
  ident: 1282_CR22
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2020.10.036
  contributor:
    fullname: W Kim
– volume: 28
  start-page: 4030
  issue: 7
  year: 2021
  ident: 1282_CR19
  publication-title: Ann Surg Oncol
  doi: 10.1245/s10434-020-09371-z
  contributor:
    fullname: F Tang
– volume: 170
  start-page: 1096
  issue: 6
  year: 2017
  ident: 1282_CR57
  publication-title: Cell
  doi: 10.1016/j.cell.2017.08.004
  contributor:
    fullname: Y Grinberg-Bleyer
– volume: 570
  start-page: 112
  issue: 7759
  year: 2019
  ident: 1282_CR60
  publication-title: Nature
  doi: 10.1038/s41586-019-1215-2
  contributor:
    fullname: M Di Pilato
– volume: 5
  start-page: 3
  issue: 1
  year: 2017
  ident: 1282_CR23
  publication-title: Cancer Immunol Res
  doi: 10.1158/2326-6066.CIR-16-0297
  contributor:
    fullname: DI Gabrilovich
– volume: 39
  start-page: 49
  issue: 1
  year: 2020
  ident: 1282_CR338
  publication-title: J Exp Clin Cancer Res
  doi: 10.1186/s13046-020-01546-6
  contributor:
    fullname: E Masoumi
– ident: 1282_CR237
  doi: 10.1136/jitc-2020-001341
– volume: 7
  start-page: 339
  issue: 1
  year: 2019
  ident: 1282_CR340
  publication-title: J Immunother Cancer
  doi: 10.1186/s40425-019-0785-8
  contributor:
    fullname: HR Kim
– volume: 54
  start-page: 885
  issue: 5
  year: 2021
  ident: 1282_CR20
  publication-title: Immunity
  doi: 10.1016/j.immuni.2021.03.022
  contributor:
    fullname: E Güç
– volume: 32
  issue: 47
  year: 2020
  ident: 1282_CR231
  publication-title: Adv Mater
  doi: 10.1002/adma.202004853
  contributor:
    fullname: L Rao
– volume: 35
  start-page: S185
  issue: Suppl
  year: 2015
  ident: 1282_CR9
  publication-title: Semin Cancer Biol
  doi: 10.1016/j.semcancer.2015.03.004
  contributor:
    fullname: DS Vinay
– volume: 8
  issue: 2
  year: 2020
  ident: 1282_CR310
  publication-title: J Immunother Cancer.
  doi: 10.1136/jitc-2020-000764
  contributor:
    fullname: LA Marshall
– volume: 20
  start-page: 680
  issue: 11
  year: 2020
  ident: 1282_CR343
  publication-title: Nat Rev Immunol
  doi: 10.1038/s41577-020-0296-3
  contributor:
    fullname: LE Lucca
– volume: 24
  start-page: 5990
  issue: 23
  year: 2018
  ident: 1282_CR225
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-18-0717
  contributor:
    fullname: R Shi
– volume: 97
  start-page: 1049
  issue: 8
  year: 2019
  ident: 1282_CR174
  publication-title: J Mol Med (Berl)
  doi: 10.1007/s00109-019-01795-9
  contributor:
    fullname: A Salminen
– volume: 117
  start-page: 23684
  issue: 38
  year: 2020
  ident: 1282_CR26
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.2002806117
  contributor:
    fullname: IX Chen
– volume: 1876
  issue: 1
  year: 2021
  ident: 1282_CR241
  publication-title: Biochim Biophys Acta Rev Cancer
  doi: 10.1016/j.bbcan.2021.188547
  contributor:
    fullname: M Santoni
– volume: 5
  start-page: 535
  issue: 7
  year: 2017
  ident: 1282_CR189
  publication-title: Cancer Immunol Res
  doi: 10.1158/2326-6066.CIR-16-0309
  contributor:
    fullname: F Dammeijer
– volume: 26
  start-page: 1420
  issue: 6
  year: 2020
  ident: 1282_CR100
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-19-2625
  contributor:
    fullname: S Greene
– volume: 74
  start-page: 141
  issue: 1
  year: 2014
  ident: 1282_CR157
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-13-1686
  contributor:
    fullname: P Cheng
– volume: 231
  year: 2021
  ident: 1282_CR232
  publication-title: Pharmacol Ther.
  doi: 10.1016/j.pharmthera.2021.107986
  contributor:
    fullname: AN Chamseddine
– volume: 79
  start-page: 4557
  issue: 18
  year: 2019
  ident: 1282_CR17
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-18-3962
  contributor:
    fullname: DC Hinshaw
– volume: 39
  start-page: 307
  issue: 3
  year: 2018
  ident: 1282_CR185
  publication-title: Trends Pharmacol Sci
  doi: 10.1016/j.tips.2017.11.007
  contributor:
    fullname: JE Cheong
– volume: 74
  start-page: 5057
  issue: 18
  year: 2014
  ident: 1282_CR111
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-13-3723
  contributor:
    fullname: Y Zhu
– volume: 120
  year: 2019
  ident: 1282_CR177
  publication-title: Biomed Pharmacother
  doi: 10.1016/j.biopha.2019.109458
  contributor:
    fullname: P Xu
– volume: 21
  start-page: 503
  issue: 4
  year: 2004
  ident: 1282_CR356
  publication-title: Immunity
  doi: 10.1016/j.immuni.2004.08.010
  contributor:
    fullname: CT Huang
– volume: 20
  start-page: 511
  issue: 5
  year: 2014
  ident: 1282_CR47
  publication-title: Nat Med
  doi: 10.1038/nm.3547
  contributor:
    fullname: C Schauer
– volume: 209
  start-page: 495
  issue: 3
  year: 2012
  ident: 1282_CR71
  publication-title: J Exp Med
  doi: 10.1084/jem.20111413
  contributor:
    fullname: UK Scarlett
– volume: 2
  start-page: 19
  issue: 1
  year: 2014
  ident: 1282_CR213
  publication-title: Cancer Immunol Res
  doi: 10.1158/2326-6066.CIR-13-0152
  contributor:
    fullname: LP Richman
– volume: 37
  start-page: 1234
  issue: 9
  year: 2014
  ident: 1282_CR160
  publication-title: Arch Pharm Res
  doi: 10.1007/s12272-014-0379-4
  contributor:
    fullname: M Lee
– volume: 572
  start-page: 392
  issue: 7769
  year: 2019
  ident: 1282_CR236
  publication-title: Nature
  doi: 10.1038/s41586-019-1456-0
  contributor:
    fullname: AA Barkal
– volume: 4
  issue: 7
  year: 2019
  ident: 1282_CR99
  publication-title: JCI Insight.
  doi: 10.1172/jci.insight.126853
  contributor:
    fullname: L Sun
– volume: 36
  start-page: 240
  issue: 4
  year: 2015
  ident: 1282_CR114
  publication-title: Trends Immunol
  doi: 10.1016/j.it.2015.02.005
  contributor:
    fullname: LB Rivera
– volume: 34
  start-page: 775
  issue: 5
  year: 2018
  ident: 1282_CR326
  publication-title: Cancer Cell
  doi: 10.1016/j.ccell.2018.10.007
  contributor:
    fullname: A Naing
– volume: 155
  start-page: 92
  year: 2018
  ident: 1282_CR385
  publication-title: Biomaterials
  doi: 10.1016/j.biomaterials.2017.11.017
  contributor:
    fullname: SO Stead
– volume: 61
  start-page: 1713
  issue: 10
  year: 2012
  ident: 1282_CR253
  publication-title: Cancer Immunol Immunother
  doi: 10.1007/s00262-012-1223-7
  contributor:
    fullname: C D'Alterio
– volume: 24
  start-page: 607
  issue: 3
  year: 2018
  ident: 1282_CR362
  publication-title: Cell Rep
  doi: 10.1016/j.celrep.2018.06.052
  contributor:
    fullname: X Zhang
– volume: 6
  start-page: 1186
  issue: 10
  year: 2018
  ident: 1282_CR255
  publication-title: Cancer Immunol Res
  doi: 10.1158/2326-6066.CIR-18-0045
  contributor:
    fullname: J Yang
– volume: 1
  start-page: 1153
  issue: 12
  year: 2020
  ident: 1282_CR301
  publication-title: Nat Cancer
  doi: 10.1038/s43018-020-00133-0
  contributor:
    fullname: I Solomon
– volume: 76
  start-page: 5241
  issue: 18
  year: 2016
  ident: 1282_CR115
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-15-3164
  contributor:
    fullname: E Limagne
– volume: 18
  start-page: 790
  issue: 7
  year: 2016
  ident: 1282_CR212
  publication-title: Nat Cell Biol
  doi: 10.1038/ncb3371
  contributor:
    fullname: C Baer
– volume: 9
  start-page: 239
  issue: 2
  year: 2021
  ident: 1282_CR355
  publication-title: Enable Cancer Immunol Res
  doi: 10.1158/2326-6066.CIR-20-0638
  contributor:
    fullname: KP Fabian
– volume: 34
  start-page: 2636
  issue: 22
  year: 2016
  ident: 1282_CR129
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2016.66.9697
  contributor:
    fullname: C Sternberg
– volume: 29
  start-page: 1312
  issue: 5
  year: 2018
  ident: 1282_CR378
  publication-title: Ann Oncol
  doi: 10.1093/annonc/mdy089
  contributor:
    fullname: ME Rodríguez-Ruiz
– volume: 67
  start-page: 11021
  issue: 22
  year: 2007
  ident: 1282_CR152
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-07-2593
  contributor:
    fullname: Y Nefedova
– volume: 176
  start-page: 191
  issue: 1
  year: 2006
  ident: 1282_CR281
  publication-title: J Immunol
  doi: 10.4049/jimmunol.176.1.191
  contributor:
    fullname: MC Jenmalm
– volume: 79
  start-page: 3903
  issue: 15
  year: 2019
  ident: 1282_CR193
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-18-3604
  contributor:
    fullname: F Li
– ident: 1282_CR344
  doi: 10.1126/scitranslmed.abg8693
– volume: 6
  start-page: 57
  issue: 1
  year: 2018
  ident: 1282_CR331
  publication-title: J Immunother Cancer
  doi: 10.1186/s40425-018-0360-8
  contributor:
    fullname: RD Leone
– volume: 46
  start-page: 577
  issue: 4
  year: 2017
  ident: 1282_CR302
  publication-title: Immunity
  doi: 10.1016/j.immuni.2017.03.013
  contributor:
    fullname: F Arce Vargas
– ident: 1282_CR25
  doi: 10.3390/jcm10204717
– volume: 7
  start-page: 230
  issue: 1
  year: 2019
  ident: 1282_CR24
  publication-title: J Immunother Cancer
  doi: 10.1186/s40425-019-0674-1
  contributor:
    fullname: MC Apodaca
– volume: 208
  start-page: 577
  issue: 3
  year: 2011
  ident: 1282_CR275
  publication-title: J Exp Med
  doi: 10.1084/jem.20100619
  contributor:
    fullname: L Wang
– volume: 70
  start-page: 9581
  issue: 23
  year: 2010
  ident: 1282_CR368
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-10-1379
  contributor:
    fullname: N Martin-Orozco
– volume: 35
  start-page: 10046
  issue: 38
  year: 2014
  ident: 1282_CR208
  publication-title: Biomaterials
  doi: 10.1016/j.biomaterials.2014.09.007
  contributor:
    fullname: X Zhan
– volume: 256
  year: 2020
  ident: 1282_CR206
  publication-title: Life Sci
  doi: 10.1016/j.lfs.2020.117925
  contributor:
    fullname: J Lv
– volume: 8
  issue: 1
  year: 2020
  ident: 1282_CR293
  publication-title: J Immunother Cancer.
  doi: 10.1136/jitc-2019-000433
  contributor:
    fullname: H Lind
– volume: 51
  start-page: 280
  issue: 2
  year: 2021
  ident: 1282_CR307
  publication-title: Eur J Immunol
  doi: 10.1002/eji.202048992
  contributor:
    fullname: S Dees
– volume: 7
  start-page: 12150
  year: 2016
  ident: 1282_CR11
  publication-title: Nat Commun
  doi: 10.1038/ncomms12150
  contributor:
    fullname: V Bronte
– volume: 25
  start-page: 1462
  issue: 5
  year: 2019
  ident: 1282_CR182
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-18-2882
  contributor:
    fullname: BW Labadie
– volume: 24
  start-page: 5368
  issue: 21
  year: 2018
  ident: 1282_CR305
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-18-1038
  contributor:
    fullname: A Oweida
– volume: 17
  start-page: 823
  issue: 11
  year: 2018
  ident: 1282_CR52
  publication-title: Nat Rev Drug Discov
  doi: 10.1038/nrd.2018.148
  contributor:
    fullname: A Sharabi
– volume: 181
  start-page: 4666
  issue: 7
  year: 2008
  ident: 1282_CR123
  publication-title: J Immunol
  doi: 10.4049/jimmunol.181.7.4666
  contributor:
    fullname: P Sinha
– ident: 1282_CR235
  doi: 10.1158/2159-8290.CD-RW2019-123
– volume: 5
  start-page: 789
  issue: 12
  year: 2019
  ident: 1282_CR41
  publication-title: Trends Cancer
  doi: 10.1016/j.trecan.2019.10.013
  contributor:
    fullname: T Keeley
– ident: 1282_CR313
  doi: 10.1158/1078-0432.CCR-19-1090
– volume: 4
  issue: 6
  year: 2015
  ident: 1282_CR75
  publication-title: Oncoimmunology
  doi: 10.1080/2162402X.2015.1008355
  contributor:
    fullname: A Pedroza-Gonzalez
– volume: 65
  start-page: 2964
  issue: 7
  year: 2005
  ident: 1282_CR209
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-04-4037
  contributor:
    fullname: P Allavena
– volume: 15
  start-page: 96
  issue: 2
  year: 2015
  ident: 1282_CR124
  publication-title: Nat Rev Cancer
  doi: 10.1038/nrc3893
  contributor:
    fullname: AR Bresnick
– volume: 153
  start-page: 21
  issue: 1
  year: 2015
  ident: 1282_CR163
  publication-title: Breast Cancer Res Treat
  doi: 10.1007/s10549-015-3508-y
  contributor:
    fullname: P Forghani
– volume: 33
  start-page: 949
  issue: 5
  year: 2012
  ident: 1282_CR40
  publication-title: Carcinogenesis
  doi: 10.1093/carcin/bgs123
  contributor:
    fullname: ZG Fridlender
– volume: 196
  start-page: 2167
  issue: 5
  year: 2016
  ident: 1282_CR168
  publication-title: J Immunol
  doi: 10.4049/jimmunol.1501853
  contributor:
    fullname: SH Albeituni
– volume: 19
  start-page: 76
  issue: 1
  year: 2018
  ident: 1282_CR238
  publication-title: Nat Immunol
  doi: 10.1038/s41590-017-0004-z
  contributor:
    fullname: AA Barkal
– volume: 210
  start-page: 1711
  issue: 9
  year: 2013
  ident: 1282_CR266
  publication-title: J Exp Med
  doi: 10.1084/jem.20130440
  contributor:
    fullname: L Raccosta
– volume: 31
  start-page: 2172
  issue: 10
  year: 2017
  ident: 1282_CR94
  publication-title: Leukemia
  doi: 10.1038/leu.2017.21
  contributor:
    fullname: EA Eksioglu
– volume: 118
  start-page: 5498
  issue: 20
  year: 2011
  ident: 1282_CR138
  publication-title: Blood
  doi: 10.1182/blood-2011-07-365825
  contributor:
    fullname: N Obermajer
– volume: 32
  start-page: 996
  issue: 6
  year: 2020
  ident: 1282_CR372
  publication-title: Cell Metab
  doi: 10.1016/j.cmet.2020.10.022
  contributor:
    fullname: W Su
– volume: 157
  start-page: 198
  issue: 3
  year: 2019
  ident: 1282_CR342
  publication-title: Immunology
  doi: 10.1111/imm.13058
  contributor:
    fullname: MA Moreno Ayala
– volume: 3
  start-page: 161
  issue: 2
  year: 2015
  ident: 1282_CR178
  publication-title: Cancer Immunol Res
  doi: 10.1158/2326-6066.CIR-14-0137
  contributor:
    fullname: I Théate
– volume: 67
  start-page: 1112
  issue: 6
  year: 2018
  ident: 1282_CR199
  publication-title: Gut
  doi: 10.1136/gutjnl-2017-313738
  contributor:
    fullname: TM Nywening
– volume: 47
  start-page: 235
  year: 2019
  ident: 1282_CR95
  publication-title: EBioMedicine
  doi: 10.1016/j.ebiom.2019.08.025
  contributor:
    fullname: L Fultang
– volume: 14
  start-page: 282
  issue: 1
  year: 2016
  ident: 1282_CR86
  publication-title: J Transl Med
  doi: 10.1186/s12967-016-1037-z
  contributor:
    fullname: E Eriksson
– volume: 154
  start-page: 3
  issue: 1
  year: 2018
  ident: 1282_CR76
  publication-title: Immunology
  doi: 10.1111/imm.12888
  contributor:
    fullname: M Collin
– volume: 184
  start-page: 3998
  issue: 15
  year: 2021
  ident: 1282_CR347
  publication-title: Cell
  doi: 10.1016/j.cell.2021.05.027
  contributor:
    fullname: F Marangoni
– volume: 23
  start-page: 587
  issue: 2
  year: 2017
  ident: 1282_CR113
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-16-0387
  contributor:
    fullname: N Horikawa
– volume: 4
  start-page: 869
  issue: 10
  year: 2016
  ident: 1282_CR155
  publication-title: Cancer Immunol Res
  doi: 10.1158/2326-6066.CIR-15-0230
  contributor:
    fullname: AH Long
– volume: 77
  start-page: 4684
  issue: 17
  year: 2017
  ident: 1282_CR335
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-17-0393
  contributor:
    fullname: A Young
– volume: 10
  start-page: 1510
  issue: 6
  year: 2021
  ident: 1282_CR276
  publication-title: Cells.
  doi: 10.3390/cells10061510
  contributor:
    fullname: O Yajuk
– volume: 190
  start-page: 222
  issue: 1
  year: 2020
  ident: 1282_CR258
  publication-title: Am J Pathol
  doi: 10.1016/j.ajpath.2019.09.016
  contributor:
    fullname: L Wu
– volume: 10
  start-page: 58
  issue: 1
  year: 2017
  ident: 1282_CR31
  publication-title: J Hematol Oncol
  doi: 10.1186/s13045-017-0430-2
  contributor:
    fullname: L Yang
– volume: 23
  start-page: 190
  issue: 3
  year: 2013
  ident: 1282_CR267
  publication-title: Semin Cancer Biol
  doi: 10.1016/j.semcancer.2012.12.002
  contributor:
    fullname: M van Egmond
– volume: 184
  start-page: 112
  year: 2018
  ident: 1282_CR289
  publication-title: Pharmacol Ther
  doi: 10.1016/j.pharmthera.2017.11.004
  contributor:
    fullname: P Eser
– volume: 22
  start-page: 1897
  issue: 8
  year: 2016
  ident: 1282_CR374
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-15-1399
  contributor:
    fullname: KF Bol
– volume: 569
  start-page: 73
  issue: 7754
  year: 2019
  ident: 1282_CR172
  publication-title: Nature
  doi: 10.1038/s41586-019-1118-2
  contributor:
    fullname: F Veglia
– volume: 17
  start-page: 588
  issue: 8
  year: 2018
  ident: 1282_CR122
  publication-title: Nat Rev Drug Discov
  doi: 10.1038/nrd.2018.97
  contributor:
    fullname: MSJ Mangan
– volume: 4
  issue: 22
  year: 2019
  ident: 1282_CR117
  publication-title: JCI Insight.
  doi: 10.1172/jci.insight.130748
  contributor:
    fullname: DM Peereboom
– volume: 11
  issue: 6
  year: 2021
  ident: 1282_CR91
  publication-title: Clin Transl Med
  doi: 10.1002/ctm2.434
  contributor:
    fullname: D Rinchai
– volume: 14
  start-page: 34
  issue: 1
  year: 2013
  ident: 1282_CR279
  publication-title: Nat Immunol
  doi: 10.1038/ni.2456
  contributor:
    fullname: J Wang
– volume: 522
  start-page: 349
  issue: 7556
  year: 2015
  ident: 1282_CR44
  publication-title: Nature
  doi: 10.1038/nature14407
  contributor:
    fullname: V Finisguerra
– volume: 40
  start-page: 569
  issue: 4
  year: 2014
  ident: 1282_CR359
  publication-title: Immunity
  doi: 10.1016/j.immuni.2014.02.012
  contributor:
    fullname: N Joller
– volume: 145
  start-page: 569
  issue: 2
  year: 2019
  ident: 1282_CR125
  publication-title: Int J Cancer
  doi: 10.1002/ijc.31982
  contributor:
    fullname: R Kinoshita
– volume: 190
  start-page: 458
  issue: 1
  year: 2013
  ident: 1282_CR328
  publication-title: J Immunol
  doi: 10.4049/jimmunol.1201325
  contributor:
    fullname: KL Han
– volume: 591
  start-page: 652
  issue: 7851
  year: 2021
  ident: 1282_CR349
  publication-title: Nature
  doi: 10.1038/s41586-021-03326-4
  contributor:
    fullname: R Zappasodi
– volume: 8
  issue: 10
  year: 2019
  ident: 1282_CR126
  publication-title: Oncoimmunology
  doi: 10.1080/2162402X.2015.1072672
  contributor:
    fullname: L Shen
– volume: 9
  issue: 7
  year: 2021
  ident: 1282_CR252
  publication-title: J Immunother Cancer.
  doi: 10.1136/jitc-2020-002242
  contributor:
    fullname: J Faget
– volume: 77
  start-page: 1108
  issue: 5
  year: 2017
  ident: 1282_CR353
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-16-0797
  contributor:
    fullname: AE Mahne
– ident: 1282_CR381
  doi: 10.1136/jitc-2020-000772
– volume: 81
  start-page: 5977
  issue: 23
  year: 2021
  ident: 1282_CR4
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-21-1148
  contributor:
    fullname: JC Valencia
– volume: 12
  start-page: 877
  issue: 1
  year: 2021
  ident: 1282_CR244
  publication-title: Nat Commun
  doi: 10.1038/s41467-021-20893-2
  contributor:
    fullname: A Rodriguez-Garcia
– volume: 12
  start-page: 253
  issue: 4
  year: 2012
  ident: 1282_CR12
  publication-title: Nat Rev Immunol
  doi: 10.1038/nri3175
  contributor:
    fullname: DI Gabrilovich
– volume: 145
  start-page: 3376
  issue: 12
  year: 2019
  ident: 1282_CR135
  publication-title: Int J Cancer
  doi: 10.1002/ijc.32624
  contributor:
    fullname: J Mohrherr
– volume: 15
  start-page: 458
  issue: 5
  year: 2018
  ident: 1282_CR65
  publication-title: Cell Mol Immunol
  doi: 10.1038/s41423-018-0004-4
  contributor:
    fullname: HM Knochelmann
– volume: 76
  start-page: 2125
  issue: 8
  year: 2016
  ident: 1282_CR90
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-15-1490
  contributor:
    fullname: A Stiff
– volume: 6
  start-page: 362
  issue: 1
  year: 2021
  ident: 1282_CR84
  publication-title: Signal Transduct Target Ther
  doi: 10.1038/s41392-021-00670-9
  contributor:
    fullname: K Li
– volume: 6
  start-page: 1561
  issue: 12
  year: 2018
  ident: 1282_CR146
  publication-title: Cancer Immunol Res
  doi: 10.1158/2326-6066.CIR-18-0070
  contributor:
    fullname: BJ Christmas
– volume: 215
  start-page: 877
  issue: 3
  year: 2018
  ident: 1282_CR215
  publication-title: J Exp Med
  doi: 10.1084/jem.20171435
  contributor:
    fullname: CJ Perry
– volume: 5
  issue: 8
  year: 2016
  ident: 1282_CR336
  publication-title: Oncoimmunology
  doi: 10.1080/2162402X.2016.1208875
  contributor:
    fullname: CM Hay
– volume: 8
  start-page: 1568
  issue: 12
  year: 2020
  ident: 1282_CR373
  publication-title: Cancer Immunol Res
  doi: 10.1158/2326-6066.CIR-20-0034
  contributor:
    fullname: RCA Sainson
– volume: 24
  start-page: 631
  issue: 5
  year: 2013
  ident: 1282_CR97
  publication-title: Cancer Cell
  doi: 10.1016/j.ccr.2013.10.009
  contributor:
    fullname: H Katoh
– volume: 9
  start-page: 1777625
  issue: 1
  year: 2020
  ident: 1282_CR186
  publication-title: Oncoimmunology
  doi: 10.1080/2162402X.2020.1777625
  contributor:
    fullname: J Le Naour
– volume: 16
  start-page: 5067
  issue: 20
  year: 2010
  ident: 1282_CR304
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-10-1757
  contributor:
    fullname: JF Jacobs
– volume: 253
  start-page: 247
  issue: 3
  year: 2021
  ident: 1282_CR249
  publication-title: J Pathol
  doi: 10.1002/path.5585
  contributor:
    fullname: Z Niu
– volume: 19
  start-page: 695
  issue: 8
  year: 2018
  ident: 1282_CR181
  publication-title: Cancer Biol Ther
  doi: 10.1080/15384047.2018.1450116
  contributor:
    fullname: F Li
– volume: 176
  start-page: 998
  issue: 5
  year: 2019
  ident: 1282_CR262
  publication-title: Cell
  doi: 10.1016/j.cell.2018.12.040
  contributor:
    fullname: C Jin
– volume: 6
  start-page: 47
  issue: 1
  year: 2018
  ident: 1282_CR291
  publication-title: J Immunother Cancer
  doi: 10.1186/s40425-018-0356-4
  contributor:
    fullname: RB Holmgaard
– volume: 26
  start-page: 878
  issue: 6
  year: 2020
  ident: 1282_CR257
  publication-title: Nat Med
  doi: 10.1038/s41591-020-0880-x
  contributor:
    fullname: B Bockorny
– volume: 6
  start-page: 1260
  issue: 10
  year: 2018
  ident: 1282_CR34
  publication-title: Cancer Immunol Res
  doi: 10.1158/2326-6066.CIR-17-0537
  contributor:
    fullname: GP Hartley
– volume: 72
  start-page: 831
  issue: 4
  year: 2012
  ident: 1282_CR82
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-11-3110
  contributor:
    fullname: P Pittoni
– volume: 116
  start-page: 997
  issue: 3
  year: 2019
  ident: 1282_CR227
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.1721434116
  contributor:
    fullname: G Hutter
– volume: 7
  start-page: 240
  issue: 1
  year: 2019
  ident: 1282_CR104
  publication-title: J Immunother Cancer
  doi: 10.1186/s40425-019-0706-x
  contributor:
    fullname: M Bilusic
– volume: 177
  start-page: 556
  issue: 3
  year: 2019
  ident: 1282_CR299
  publication-title: Cell
  doi: 10.1016/j.cell.2019.02.005
  contributor:
    fullname: M Binnewies
– volume: 6
  start-page: e1261779
  issue: 1
  year: 2017
  ident: 1282_CR319
  publication-title: Oncoimmunology
  doi: 10.1080/2162402X.2016.1261779
  contributor:
    fullname: G Shayan
– volume: 210
  start-page: 2321
  issue: 11
  year: 2013
  ident: 1282_CR256
  publication-title: J Exp Med
  doi: 10.1084/jem.20130056
  contributor:
    fullname: S Devi
– volume: 132
  start-page: 215
  issue: 1
  year: 2012
  ident: 1282_CR151
  publication-title: Breast Cancer Res Treat
  doi: 10.1007/s10549-011-1889-0
  contributor:
    fullname: AJ Montero
– volume: 74
  start-page: 1032
  issue: 4
  year: 2014
  ident: 1282_CR6
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-13-2800
  contributor:
    fullname: KY Aguilera
– volume: 80
  start-page: 3145
  issue: 15
  year: 2020
  ident: 1282_CR134
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-19-3670
  contributor:
    fullname: AD Smith
– volume: 7
  start-page: 13720
  year: 2016
  ident: 1282_CR70
  publication-title: Nat Commun
  doi: 10.1038/ncomms13720
  contributor:
    fullname: D Laoui
– volume: 9
  issue: 8
  year: 2021
  ident: 1282_CR242
  publication-title: J Immunother Cancer.
  doi: 10.1136/jitc-2021-002741
  contributor:
    fullname: SM Abdin
– volume: 73
  start-page: 3007
  issue: 10
  year: 2013
  ident: 1282_CR132
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-12-4601
  contributor:
    fullname: TA Mace
– volume: 5
  start-page: 35
  issue: 1
  year: 2015
  ident: 1282_CR205
  publication-title: Cancer Discov
  doi: 10.1158/2159-8290.CD-14-0621
  contributor:
    fullname: S Junankar
– volume: 7
  start-page: 1154
  issue: 10
  year: 2017
  ident: 1282_CR245
  publication-title: Cancer Discov
  doi: 10.1158/2159-8290.CD-16-0850
  contributor:
    fullname: M Ruella
– volume: 24
  start-page: 62
  issue: 1
  year: 2018
  ident: 1282_CR159
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-17-0357
  contributor:
    fullname: G Shayan
– volume: 9
  start-page: 1792058
  issue: 1
  year: 2020
  ident: 1282_CR380
  publication-title: Oncoimmunology
  doi: 10.1080/2162402X.2020.1792058
  contributor:
    fullname: T Lövgren
– volume: 8
  start-page: 1395
  issue: 1
  year: 2017
  ident: 1282_CR286
  publication-title: Nat Commun
  doi: 10.1038/s41467-017-01385-8
  contributor:
    fullname: P Wang
– volume: 204
  start-page: 1257
  issue: 6
  year: 2007
  ident: 1282_CR329
  publication-title: J Exp Med
  doi: 10.1084/jem.20062512
  contributor:
    fullname: S Deaglio
– volume: 18
  start-page: 648
  issue: 10
  year: 2018
  ident: 1282_CR67
  publication-title: Nat Rev Immunol
  doi: 10.1038/s41577-018-0046-y
  contributor:
    fullname: R Spolski
– volume: 7
  start-page: e1442167
  issue: 7
  year: 2018
  ident: 1282_CR176
  publication-title: Oncoimmunology
  doi: 10.1080/2162402X.2018.1442167
  contributor:
    fullname: G Qin
– volume: 9
  issue: 10
  year: 2021
  ident: 1282_CR1
  publication-title: J Immunother Cancer.
  doi: 10.1136/jitc-2021-003623
  contributor:
    fullname: AM Heeren
– volume: 78
  start-page: 3220
  issue: 12
  year: 2018
  ident: 1282_CR153
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-17-3415
  contributor:
    fullname: R Bauer
– volume: 114
  start-page: E10578
  issue: 49
  year: 2017
  ident: 1282_CR271
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.1710877114
  contributor:
    fullname: NG Ring
– volume: 490
  start-page: 174
  year: 2020
  ident: 1282_CR300
  publication-title: Cancer Lett
  doi: 10.1016/j.canlet.2020.07.022
  contributor:
    fullname: R Saleh
– volume: 75
  start-page: 2822
  issue: 14
  year: 2015
  ident: 1282_CR49
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-15-0125
  contributor:
    fullname: X Ma
– volume: 63
  start-page: 282
  year: 2018
  ident: 1282_CR154
  publication-title: Int Immunopharmacol
  doi: 10.1016/j.intimp.2018.08.007
  contributor:
    fullname: RP Tobin
– volume: 103
  start-page: 12493
  issue: 33
  year: 2006
  ident: 1282_CR50
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.0601807103
  contributor:
    fullname: H Nozawa
– volume: 77
  start-page: 1892
  issue: 8
  year: 2017
  ident: 1282_CR317
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-16-1839
  contributor:
    fullname: S Ahmad
– volume: 19
  start-page: 2342
  issue: 9
  year: 2013
  ident: 1282_CR221
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-12-2623
  contributor:
    fullname: MW Khan
– ident: 1282_CR64
  doi: 10.1126/scisignal.aak9702
– volume: 7
  start-page: e1408745
  issue: 3
  year: 2018
  ident: 1282_CR203
  publication-title: Oncoimmunology
  doi: 10.1080/2162402X.2017.1408745
  contributor:
    fullname: YM Meng
– volume: 11
  start-page: 1357
  issue: 8
  year: 2016
  ident: 1282_CR224
  publication-title: J Thorac Oncol
  doi: 10.1016/j.jtho.2016.04.015
  contributor:
    fullname: PA Levin
– volume: 7
  year: 2018
  ident: 1282_CR246
  publication-title: Elife.
  doi: 10.7554/eLife.36688
  contributor:
    fullname: MA Morrissey
– volume: 3
  start-page: 583
  issue: 8
  year: 2017
  ident: 1282_CR62
  publication-title: Trends Cancer
  doi: 10.1016/j.trecan.2017.06.005
  contributor:
    fullname: H Wang
– volume: 12
  start-page: 655
  issue: 5
  year: 2017
  ident: 1282_CR127
  publication-title: Target Oncol
  doi: 10.1007/s11523-017-0525-2
  contributor:
    fullname: B Escudier
– volume: 52
  start-page: 1560
  issue: 9
  year: 2012
  ident: 1282_CR150
  publication-title: Free Radic Biol Med
  doi: 10.1016/j.freeradbiomed.2012.02.007
  contributor:
    fullname: CM Diaz-Montero
– volume: 10
  issue: 3
  year: 2018
  ident: 1282_CR63
  publication-title: Cold Spring Harb Perspect Biol.
  doi: 10.1101/cshperspect.a028597
  contributor:
    fullname: KH Toomer
– volume: 17
  start-page: 887
  issue: 12
  year: 2018
  ident: 1282_CR29
  publication-title: Nat Rev Drug Discov
  doi: 10.1038/nrd.2018.169
  contributor:
    fullname: L Cassetta
– ident: 1282_CR348
  doi: 10.1126/sciimmunol.aba0759
– volume: 457
  start-page: 168
  year: 2019
  ident: 1282_CR61
  publication-title: Cancer Lett
  doi: 10.1016/j.canlet.2019.05.003
  contributor:
    fullname: R Saleh
– volume: 21
  start-page: 39
  issue: 1
  year: 2015
  ident: 1282_CR137
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-14-1711
  contributor:
    fullname: DT Weed
– volume: 183
  year: 2021
  ident: 1282_CR28
  publication-title: Biochem Pharmacol
  doi: 10.1016/j.bcp.2020.114354
  contributor:
    fullname: N Cheng
– volume: 4
  start-page: 303
  issue: 4
  year: 2016
  ident: 1282_CR140
  publication-title: Cancer Immunol Res
  doi: 10.1158/2326-6066.CIR-15-0157
  contributor:
    fullname: JL Wong
– volume: 11
  start-page: 1590
  year: 2020
  ident: 1282_CR27
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2020.01590
  contributor:
    fullname: E Peranzoni
– volume: 61
  start-page: 1591
  issue: 5
  year: 2015
  ident: 1282_CR202
  publication-title: Hepatology
  doi: 10.1002/hep.27665
  contributor:
    fullname: Y Chen
– volume: 91
  start-page: 167
  issue: 1
  year: 2012
  ident: 1282_CR10
  publication-title: J Leukoc Biol
  doi: 10.1189/jlb.0311177
  contributor:
    fullname: JI Youn
– volume: 30
  start-page: 486
  issue: 3
  year: 2019
  ident: 1282_CR233
  publication-title: Ann Oncol
  doi: 10.1093/annonc/mdz006
  contributor:
    fullname: CH Takimoto
– volume: 52
  start-page: 856
  issue: 5
  year: 2020
  ident: 1282_CR101
  publication-title: Immunity
  doi: 10.1016/j.immuni.2020.03.001
  contributor:
    fullname: Á Teijeira
– volume: 19
  start-page: 1264
  issue: 10
  year: 2013
  ident: 1282_CR191
  publication-title: Nat Med
  doi: 10.1038/nm.3337
  contributor:
    fullname: SM Pyonteck
– volume: 522
  start-page: 345
  issue: 7556
  year: 2015
  ident: 1282_CR259
  publication-title: Nature
  doi: 10.1038/nature14282
  contributor:
    fullname: SB Coffelt
– volume: 110
  start-page: 17957
  issue: 44
  year: 2013
  ident: 1282_CR278
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.1221535110
  contributor:
    fullname: J Baudhuin
– volume: 22
  start-page: 58
  year: 2017
  ident: 1282_CR198
  publication-title: EBioMedicine
  doi: 10.1016/j.ebiom.2017.07.014
  contributor:
    fullname: W Yao
– volume: 13
  start-page: 153
  issue: 1
  year: 2020
  ident: 1282_CR250
  publication-title: J Hematol Oncol
  doi: 10.1186/s13045-020-00983-2
  contributor:
    fullname: L Zhang
– volume: 121
  start-page: 837
  issue: 10
  year: 2019
  ident: 1282_CR248
  publication-title: Br J Cancer
  doi: 10.1038/s41416-019-0578-3
  contributor:
    fullname: W Zhang
– volume: 81
  start-page: 3295
  issue: 12
  year: 2021
  ident: 1282_CR156
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-20-3564
  contributor:
    fullname: R Li
– volume: 16
  start-page: 601
  issue: 10
  year: 2019
  ident: 1282_CR38
  publication-title: Nat Rev Clin Oncol
  doi: 10.1038/s41571-019-0222-4
  contributor:
    fullname: ME Shaul
– volume: 3
  start-page: 190
  year: 2012
  ident: 1282_CR332
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2012.00190
  contributor:
    fullname: A Ohta
– volume: 11
  start-page: 9536
  issue: 9
  year: 2017
  ident: 1282_CR187
  publication-title: ACS Nano
  doi: 10.1021/acsnano.7b05465
  contributor:
    fullname: Y Qian
– volume: 3
  start-page: 149
  issue: 2
  year: 2015
  ident: 1282_CR358
  publication-title: Cancer Immunol Res
  doi: 10.1158/2326-6066.CIR-14-0118
  contributor:
    fullname: S Chen
– volume: 38
  start-page: 372
  issue: 1
  year: 2019
  ident: 1282_CR188
  publication-title: J Exp Clin Cancer Res
  doi: 10.1186/s13046-019-1357-y
  contributor:
    fullname: X Peng
– volume: 144
  start-page: 136
  issue: 1
  year: 2019
  ident: 1282_CR296
  publication-title: Int J Cancer
  doi: 10.1002/ijc.31808
  contributor:
    fullname: E Pylaeva
– volume: 2
  start-page: eaaw7843
  issue: 552
  year: 2020
  ident: 1282_CR192
  publication-title: Sci Transl Med.
  doi: 10.1126/scitranslmed.aaw7843
  contributor:
    fullname: L Akkari
– volume: 76
  start-page: 5671
  issue: 19
  year: 2016
  ident: 1282_CR312
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-16-0144
  contributor:
    fullname: AL Chang
– volume: 60
  start-page: 24
  year: 2017
  ident: 1282_CR103
  publication-title: Cancer Treat Rev
  doi: 10.1016/j.ctrv.2017.08.004
  contributor:
    fullname: C Alfaro
– volume: 11
  start-page: 582657
  year: 2020
  ident: 1282_CR79
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2020.582657
  contributor:
    fullname: J Shang
– volume: 19
  start-page: 568
  issue: 10
  year: 2019
  ident: 1282_CR280
  publication-title: Nat Rev Cancer
  doi: 10.1038/s41568-019-0183-z
  contributor:
    fullname: M Feng
– volume: 7
  start-page: 231
  issue: 1
  year: 2019
  ident: 1282_CR164
  publication-title: J Immunother Cancer
  doi: 10.1186/s40425-019-0676-z
  contributor:
    fullname: W Gao
– volume: 7
  start-page: 1175
  issue: 7
  year: 2019
  ident: 1282_CR309
  publication-title: Cancer Immunol Res
  doi: 10.1158/2326-6066.CIR-18-0751
  contributor:
    fullname: S Maeda
– volume: 17
  start-page: 1
  issue: 1
  year: 2020
  ident: 1282_CR16
  publication-title: Cell Mol Immunol
  doi: 10.1038/s41423-019-0306-1
  contributor:
    fullname: K Nakamura
– volume: 11
  start-page: 890
  issue: 7
  year: 2011
  ident: 1282_CR167
  publication-title: Int Immunopharmacol
  doi: 10.1016/j.intimp.2011.01.007
  contributor:
    fullname: J Zhou
– volume: 6
  start-page: 75
  issue: 1
  year: 2021
  ident: 1282_CR201
  publication-title: Signal Transduct Target Ther
  doi: 10.1038/s41392-021-00484-9
  contributor:
    fullname: X Xiang
– volume: 216
  start-page: 176
  issue: 1
  year: 2019
  ident: 1282_CR39
  publication-title: J Exp Med
  doi: 10.1084/jem.20181170
  contributor:
    fullname: W Lee
– volume: 8
  start-page: 263
  issue: 3
  year: 2018
  ident: 1282_CR170
  publication-title: Cancer Discov.
  contributor:
    fullname: LXR agonism depletes MDSCs to promote antitumor immunity
– volume: 102
  start-page: 317
  issue: 2
  year: 2017
  ident: 1282_CR69
  publication-title: J Leukoc Biol
  doi: 10.1189/jlb.4MR1116-466R
  contributor:
    fullname: J Keirsse
– volume: 12
  start-page: 2582
  issue: 1
  year: 2021
  ident: 1282_CR351
  publication-title: Nat Commun
  doi: 10.1038/s41467-021-22885-8
  contributor:
    fullname: Z Amoozgar
– volume: 7
  start-page: 1700
  issue: 10
  year: 2019
  ident: 1282_CR361
  publication-title: Cancer Immunol Res
  doi: 10.1158/2326-6066.CIR-18-0725
  contributor:
    fullname: L Wu
– volume: 6
  start-page: 50
  year: 2016
  ident: 1282_CR109
  publication-title: EBioMedicine
  doi: 10.1016/j.ebiom.2016.02.024
  contributor:
    fullname: RB Holmgaard
– ident: 1282_CR283
  doi: 10.1136/jitc-2020-000889
– volume: 16
  start-page: 137
  issue: 1
  year: 2017
  ident: 1282_CR263
  publication-title: Mol Cancer
  doi: 10.1186/s12943-017-0707-7
  contributor:
    fullname: A Ocana
– volume: 16
  start-page: 356
  issue: 6
  year: 2019
  ident: 1282_CR341
  publication-title: Nat Rev Clin Oncol
  doi: 10.1038/s41571-019-0175-7
  contributor:
    fullname: Y Togashi
– volume: 14
  start-page: 585
  issue: 9
  year: 2014
  ident: 1282_CR261
  publication-title: Nat Rev Immunol
  doi: 10.1038/nri3707
  contributor:
    fullname: SL Gaffen
– volume: 21
  start-page: 2325
  issue: 10
  year: 2015
  ident: 1282_CR230
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-14-1399
  contributor:
    fullname: M Cioffi
– volume: 27
  start-page: 4669
  issue: 17
  year: 2021
  ident: 1282_CR18
  publication-title: Clin Cancer Res.
  doi: 10.1158/1078-0432.CCR-20-4459
  contributor:
    fullname: M Taki
– volume: 276
  start-page: 121
  issue: 1
  year: 2017
  ident: 1282_CR330
  publication-title: Immunol Rev
  doi: 10.1111/imr.12528
  contributor:
    fullname: B Allard
– volume: 587
  start-page: 121
  issue: 7832
  year: 2020
  ident: 1282_CR5
  publication-title: Nature
  doi: 10.1038/s41586-020-2850-3
  contributor:
    fullname: S Li
– volume: 30
  start-page: 302
  issue: 1
  year: 2012
  ident: 1282_CR207
  publication-title: Biotechnol Adv
  doi: 10.1016/j.biotechadv.2011.06.018
  contributor:
    fullname: M Marra
– volume: 18
  start-page: 180
  issue: 1
  year: 2019
  ident: 1282_CR56
  publication-title: Mol Cancer
  doi: 10.1186/s12943-019-1110-3
  contributor:
    fullname: JH Kim
– volume: 7
  start-page: 835
  issue: 8
  year: 2014
  ident: 1282_CR147
  publication-title: Cancer Prev Res (Phila)
  doi: 10.1158/1940-6207.CAPR-14-0094
  contributor:
    fullname: K Hiramoto
– volume: 16
  start-page: 138
  issue: 2
  year: 2019
  ident: 1282_CR363
  publication-title: Cell Mol Immunol
  doi: 10.1038/cmi.2018.8
  contributor:
    fullname: P Kumar
– volume: 6
  start-page: 24249
  year: 2016
  ident: 1282_CR323
  publication-title: Sci Rep
  doi: 10.1038/srep24249
  contributor:
    fullname: S Wang
– volume: 16
  start-page: 183
  issue: 3
  year: 2009
  ident: 1282_CR43
  publication-title: Cancer Cell
  doi: 10.1016/j.ccr.2009.06.017
  contributor:
    fullname: ZG Fridlender
– volume: 5
  issue: 1
  year: 2016
  ident: 1282_CR295
  publication-title: Oncoimmunology
  doi: 10.1080/2162402X.2015.1067744
  contributor:
    fullname: S Shrestha
– volume: 14
  start-page: R32
  issue: 1
  year: 2012
  ident: 1282_CR81
  publication-title: Arthritis Res Ther
  doi: 10.1186/ar3736
  contributor:
    fullname: NA Carter
– volume: 130
  start-page: 5380
  issue: 10
  year: 2020
  ident: 1282_CR36
  publication-title: J Clin Invest
  doi: 10.1172/JCI137110
  contributor:
    fullname: E Loeuillard
– volume: 5
  start-page: 35
  issue: 1
  year: 2020
  ident: 1282_CR226
  publication-title: Signal Transduct Target Ther
  doi: 10.1038/s41392-020-0124-z
  contributor:
    fullname: X Wang
– volume: 18
  start-page: 749
  issue: 10
  year: 2019
  ident: 1282_CR298
  publication-title: Nat Rev Drug Discov
  doi: 10.1038/s41573-019-0041-4
  contributor:
    fullname: LMR Ferreira
– volume: 499
  start-page: 485
  issue: 7459
  year: 2013
  ident: 1282_CR371
  publication-title: Nature
  doi: 10.1038/nature12297
  contributor:
    fullname: H Zeng
– ident: 1282_CR379
  doi: 10.1084/jem.20191369
– volume: 50
  start-page: 871
  issue: 4
  year: 2019
  ident: 1282_CR7
  publication-title: Immunity
  doi: 10.1016/j.immuni.2019.03.020
  contributor:
    fullname: W Ouyang
– volume: 196
  start-page: 3470
  issue: 8
  year: 2016
  ident: 1282_CR148
  publication-title: J Immunol
  doi: 10.4049/jimmunol.1501785
  contributor:
    fullname: DW Beury
– volume: 30
  start-page: 1381
  issue: 8
  year: 2019
  ident: 1282_CR190
  publication-title: Ann Oncol
  doi: 10.1093/annonc/mdz163
  contributor:
    fullname: CA Gomez-Roca
– volume: 7
  start-page: 61
  issue: 1
  year: 2021
  ident: 1282_CR183
  publication-title: JAMA Oncol
  doi: 10.1001/jamaoncol.2020.5572
  contributor:
    fullname: V Mariotti
– ident: 1282_CR21
  doi: 10.1136/jitc-2020-002323
– volume: 39
  start-page: 217
  issue: 1
  year: 2020
  ident: 1282_CR222
  publication-title: J Exp Clin Cancer Res
  doi: 10.1186/s13046-020-01713-9
  contributor:
    fullname: KM Ruicci
– volume: 20
  start-page: 676
  issue: 6
  year: 2014
  ident: 1282_CR96
  publication-title: Nat Med
  doi: 10.1038/nm.3560
  contributor:
    fullname: H Qin
– volume: 6
  start-page: 119
  issue: 1
  year: 2018
  ident: 1282_CR130
  publication-title: J Immunother Cancer
  doi: 10.1186/s40425-018-0436-5
  contributor:
    fullname: MJ Reilley
– volume: 26
  start-page: 5217
  issue: 19
  year: 2020
  ident: 1282_CR360
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-20-0558
  contributor:
    fullname: ZZ Yang
– volume: 7
  start-page: 1687
  issue: 10
  year: 2019
  ident: 1282_CR119
  publication-title: Cancer Immunol Res
  doi: 10.1158/2326-6066.CIR-18-0578
  contributor:
    fullname: CS Tannenbaum
– volume: 21
  start-page: 3771
  issue: 16
  year: 2015
  ident: 1282_CR131
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-14-3145
  contributor:
    fullname: DM Hossain
– volume: 77
  start-page: 2857
  issue: 11
  year: 2017
  ident: 1282_CR106
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-16-2913
  contributor:
    fullname: Y Ban
– volume: 10
  start-page: 704
  year: 2019
  ident: 1282_CR268
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2019.00704
  contributor:
    fullname: AM Brandsma
– volume: 42
  start-page: 607
  issue: 4
  year: 2015
  ident: 1282_CR78
  publication-title: Immunity
  doi: 10.1016/j.immuni.2015.04.005
  contributor:
    fullname: EC Rosser
– volume: 18
  start-page: 566
  issue: 3
  year: 2021
  ident: 1282_CR272
  publication-title: Cell Mol Immunol
  doi: 10.1038/s41423-020-00613-4
  contributor:
    fullname: A Mantovani
– volume: 9
  start-page: 676
  issue: 1
  year: 2018
  ident: 1282_CR282
  publication-title: Nat Commun
  doi: 10.1038/s41467-018-03080-8
  contributor:
    fullname: M Massara
– volume: 23
  start-page: 5358
  issue: 18
  year: 2017
  ident: 1282_CR102
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-16-2748
  contributor:
    fullname: AF Schott
– volume: 190
  start-page: 2464
  issue: 5
  year: 2013
  ident: 1282_CR87
  publication-title: J Immunol
  doi: 10.4049/jimmunol.1202781
  contributor:
    fullname: A Sevko
– volume: 136
  start-page: 2352
  issue: 10
  year: 2015
  ident: 1282_CR118
  publication-title: Int J Cancer
  doi: 10.1002/ijc.29297
  contributor:
    fullname: H Jiang
– volume: 10
  issue: 7
  year: 2018
  ident: 1282_CR284
  publication-title: Cold Spring Harb Perspect Biol.
  doi: 10.1101/cshperspect.a028530
  contributor:
    fullname: J Yan
– volume: 24
  start-page: 146
  issue: 1
  year: 2016
  ident: 1282_CR383
  publication-title: Mol Ther
  doi: 10.1038/mt.2015.175
  contributor:
    fullname: JA Katakowski
– volume: 110
  start-page: 17945
  issue: 44
  year: 2013
  ident: 1282_CR311
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.1316796110
  contributor:
    fullname: D Sugiyama
– volume: 63
  start-page: 113
  issue: 1
  year: 2015
  ident: 1282_CR83
  publication-title: Mol Immunol
  doi: 10.1016/j.molimm.2014.02.020
  contributor:
    fullname: SA Oldford
– ident: 1282_CR14
  doi: 10.3390/cells8121647
– volume: 11
  start-page: 2693
  issue: 11
  year: 2021
  ident: 1282_CR386
  publication-title: Cancer Discov
  doi: 10.1158/2159-8290.CD-21-0764
  contributor:
    fullname: A Grover
– volume: 331
  start-page: 1612
  issue: 6024
  year: 2011
  ident: 1282_CR214
  publication-title: Science
  doi: 10.1126/science.1198443
  contributor:
    fullname: GL Beatty
– volume: 70
  start-page: 3526
  issue: 9
  year: 2010
  ident: 1282_CR89
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-09-3278
  contributor:
    fullname: JS Ko
– volume: 65
  start-page: 28
  issue: 1
  year: 2014
  ident: 1282_CR247
  publication-title: Methods
  doi: 10.1016/j.ymeth.2013.06.020
  contributor:
    fullname: R Braster
– volume: 38
  start-page: 533
  issue: 4
  year: 2019
  ident: 1282_CR133
  publication-title: Oncogene
  doi: 10.1038/s41388-018-0449-z
  contributor:
    fullname: P Guha
– volume: 65
  start-page: 730
  issue: 4
  year: 2017
  ident: 1282_CR93
  publication-title: Mol Cell
  doi: 10.1016/j.molcel.2017.01.021
  contributor:
    fullname: T Hartwig
– volume: 510
  start-page: 407
  issue: 7505
  year: 2014
  ident: 1282_CR316
  publication-title: Nature
  doi: 10.1038/nature13444
  contributor:
    fullname: K Ali
– volume: 2
  start-page: 142
  issue: 2
  year: 2014
  ident: 1282_CR366
  publication-title: Cancer Immunol Res
  doi: 10.1158/2326-6066.CIR-13-0031-T
  contributor:
    fullname: WL Redmond
– volume: 245
  year: 2020
  ident: 1282_CR384
  publication-title: Biomaterials
  doi: 10.1016/j.biomaterials.2020.119983
  contributor:
    fullname: H Zhang
– volume: 8
  start-page: 1136
  issue: 1
  year: 2017
  ident: 1282_CR8
  publication-title: Nat Commun
  doi: 10.1038/s41467-017-01062-w
  contributor:
    fullname: M Sade-Feldman
– volume: 23
  start-page: 2942
  issue: 12
  year: 2017
  ident: 1282_CR92
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-16-1784
  contributor:
    fullname: GA Dominguez
– volume: 7
  start-page: 103
  issue: 1
  year: 2019
  ident: 1282_CR365
  publication-title: J Immunother Cancer
  doi: 10.1186/s40425-019-0570-8
  contributor:
    fullname: AM Kvarnhammar
– volume: 191
  start-page: 437
  issue: 4
  year: 2015
  ident: 1282_CR194
  publication-title: Am J Respir Crit Care Med
  doi: 10.1164/rccm.201406-1137OC
  contributor:
    fullname: A Schmall
– volume: 189
  start-page: 3848
  issue: 8
  year: 2012
  ident: 1282_CR74
  publication-title: J Immunol
  doi: 10.4049/jimmunol.1200819
  contributor:
    fullname: TL Sumpter
– volume: 78
  start-page: 5644
  issue: 19
  year: 2018
  ident: 1282_CR158
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-18-1229
  contributor:
    fullname: A Hashimoto
– volume: 5
  start-page: 6
  issue: 1
  year: 2020
  ident: 1282_CR243
  publication-title: Signal Transduct Target Ther
  doi: 10.1038/s41392-020-0115-0
  contributor:
    fullname: Y Tie
– volume: 4
  start-page: 941
  issue: 12
  year: 2004
  ident: 1282_CR73
  publication-title: Nat Rev Immunol
  doi: 10.1038/nri1498
  contributor:
    fullname: D Gabrilovich
– volume: 14
  start-page: 191
  issue: 1
  year: 2021
  ident: 1282_CR2
  publication-title: J Hematol Oncol.
  doi: 10.1186/s13045-021-01193-0
  contributor:
    fullname: N Tumino
– volume: 76
  start-page: 3884
  issue: 13
  year: 2016
  ident: 1282_CR210
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-15-1524
  contributor:
    fullname: L Hollander
– volume: 38
  start-page: 947
  issue: 8
  year: 2020
  ident: 1282_CR240
  publication-title: Nat Biotechnol
  doi: 10.1038/s41587-020-0462-y
  contributor:
    fullname: M Klichinsky
– volume: 124
  start-page: 99
  issue: 1
  year: 2014
  ident: 1282_CR369
  publication-title: J Clin Invest
  doi: 10.1172/JCI46266
  contributor:
    fullname: GC Sim
– volume: 5
  issue: 7
  year: 2016
  ident: 1282_CR324
  publication-title: Oncoimmunology
  doi: 10.1080/2162402X.2016.1197458
  contributor:
    fullname: IH Chan
– volume: 69
  start-page: 477
  issue: 3
  year: 2020
  ident: 1282_CR377
  publication-title: Cancer Immunol Immunother
  doi: 10.1007/s00262-019-02466-x
  contributor:
    fullname: S Boudewijns
– volume: 31
  start-page: 1336
  issue: 10
  year: 2020
  ident: 1282_CR290
  publication-title: Ann Oncol
  doi: 10.1016/j.annonc.2020.07.009
  contributor:
    fullname: D Ciardiello
– ident: 1282_CR345
  doi: 10.1073/pnas.2023739118
– volume: 37
  start-page: 193
  issue: 3
  year: 2016
  ident: 1282_CR180
  publication-title: Trends Immunol
  doi: 10.1016/j.it.2016.01.002
  contributor:
    fullname: DH Munn
– volume: 50
  start-page: 851
  issue: 4
  year: 2019
  ident: 1282_CR285
  publication-title: Immunity
  doi: 10.1016/j.immuni.2019.03.011
  contributor:
    fullname: ED Tait Wojno
– volume: 8
  start-page: 3611
  issue: 13
  year: 2018
  ident: 1282_CR220
  publication-title: Theranostics
  doi: 10.7150/thno.25613
  contributor:
    fullname: M Chavez
– volume: 14
  start-page: 211
  issue: 3
  year: 2013
  ident: 1282_CR142
  publication-title: Nat Immunol
  doi: 10.1038/ni.2526
  contributor:
    fullname: JI Youn
– volume: 31
  start-page: 61
  year: 2016
  ident: 1282_CR251
  publication-title: Cytokine Growth Factor Rev
  doi: 10.1016/j.cytogfr.2016.08.002
  contributor:
    fullname: Q Liu
– volume: 20
  start-page: 485
  issue: 9
  year: 2020
  ident: 1282_CR37
  publication-title: Nat Rev Cancer
  doi: 10.1038/s41568-020-0281-y
  contributor:
    fullname: S Jaillon
– volume: 19
  start-page: 541
  issue: 10
  year: 2019
  ident: 1282_CR234
  publication-title: Nat Rev Cancer
  doi: 10.1038/s41568-019-0193-x
  contributor:
    fullname: CA Bradley
– volume: 114
  start-page: 206
  year: 2017
  ident: 1282_CR35
  publication-title: Adv Drug Deliv Rev
  doi: 10.1016/j.addr.2017.04.010
  contributor:
    fullname: C Ngambenjawong
– volume: 7
  start-page: 700
  issue: 8
  year: 2021
  ident: 1282_CR42
  publication-title: Trends Cancer
  doi: 10.1016/j.trecan.2021.04.007
  contributor:
    fullname: T Rogers
– volume: 2
  start-page: 1080
  issue: 11
  year: 2014
  ident: 1282_CR315
  publication-title: Cancer Immunol Res
  doi: 10.1158/2326-6066.CIR-14-0095
  contributor:
    fullname: R Abu-Eid
– volume: 27
  start-page: 533
  issue: 4
  year: 2015
  ident: 1282_CR223
  publication-title: Cancer Cell
  doi: 10.1016/j.ccell.2015.03.010
  contributor:
    fullname: M Elkabets
– volume: 114
  start-page: 1117
  issue: 5
  year: 2017
  ident: 1282_CR141
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.1612920114
  contributor:
    fullname: V Prima
– volume: 16
  start-page: 37
  issue: 1
  year: 2021
  ident: 1282_CR382
  publication-title: Nat Nanotechnol
  doi: 10.1038/s41565-020-00810-2
  contributor:
    fullname: A Cifuentes-Rius
– volume: 40
  start-page: 1836
  issue: 10
  year: 2021
  ident: 1282_CR144
  publication-title: Oncogene
  doi: 10.1038/s41388-020-01636-x
  contributor:
    fullname: X Li
– volume: 20
  start-page: 724
  issue: 6
  year: 2019
  ident: 1282_CR322
  publication-title: Nat Immunol
  doi: 10.1038/s41590-019-0346-9
  contributor:
    fullname: DV Sawant
– volume: 215
  start-page: 2778
  issue: 11
  year: 2018
  ident: 1282_CR254
  publication-title: J Exp Med
  doi: 10.1084/jem.20181468
  contributor:
    fullname: M Casanova-Acebes
– volume: 20
  start-page: 158
  issue: 3
  year: 2020
  ident: 1282_CR54
  publication-title: Nat Rev Immunol
  doi: 10.1038/s41577-019-0232-6
  contributor:
    fullname: C Raffin
– volume: 31
  start-page: 2006220
  issue: 5
  year: 2021
  ident: 1282_CR229
  publication-title: Adv Funct Mater.
  doi: 10.1002/adfm.202006220
  contributor:
    fullname: X Zhou
– volume: 17
  start-page: 559
  issue: 9
  year: 2017
  ident: 1282_CR195
  publication-title: Nat Rev Immunol
  doi: 10.1038/nri.2017.49
  contributor:
    fullname: N Nagarsheth
– volume: 23
  start-page: 5187
  issue: 17
  year: 2017
  ident: 1282_CR145
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-17-0741
  contributor:
    fullname: A Orillion
– volume: 12
  start-page: 4294
  issue: 14 Pt 1
  year: 2006
  ident: 1282_CR303
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-06-0053
  contributor:
    fullname: PE Fecci
– volume: 113
  start-page: 4240
  issue: 18
  year: 2009
  ident: 1282_CR59
  publication-title: Blood
  doi: 10.1182/blood-2008-10-183251
  contributor:
    fullname: G Beriou
– volume: 78
  start-page: 157
  issue: 1
  year: 2018
  ident: 1282_CR105
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-17-0348
  contributor:
    fullname: C Blattner
– volume: 86
  start-page: 143
  issue: 3
  year: 2017
  ident: 1282_CR265
  publication-title: Scand J Immunol
  doi: 10.1111/sji.12580
  contributor:
    fullname: S Denk
– volume: 21
  start-page: 4327
  issue: 19
  year: 2015
  ident: 1282_CR314
  publication-title: Cancer Patients Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-15-0357
  contributor:
    fullname: K Kurose
– volume: 68
  start-page: 1949
  issue: 12
  year: 2019
  ident: 1282_CR162
  publication-title: Cancer Immunol Immunother
  doi: 10.1007/s00262-019-02418-5
  contributor:
    fullname: V Domankevich
– volume: 38
  start-page: 969
  issue: 3
  year: 2016
  ident: 1282_CR333
  publication-title: Int J Mol Med
  doi: 10.3892/ijmm.2016.2679
  contributor:
    fullname: R Bao
– volume: 42
  start-page: 1116
  issue: 6
  year: 2015
  ident: 1282_CR66
  publication-title: Immunity
  doi: 10.1016/j.immuni.2015.05.023
  contributor:
    fullname: V Kalia
SSID ssj0061920
Score 2.6794958
SecondaryResourceType review_article
Snippet Immunotherapies like the adoptive transfer of gene-engineered T cells and immune checkpoint inhibitors are novel therapeutic modalities for advanced cancers....
Abstract Immunotherapies like the adoptive transfer of gene-engineered T cells and immune checkpoint inhibitors are novel therapeutic modalities for advanced...
SourceID doaj
pubmedcentral
proquest
gale
crossref
pubmed
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage 61
SubjectTerms Adoptive transfer
Angiogenesis
Antigens
Biomarkers
Bone marrow
Cancer
Cytokines
Dendritic cells
Development and progression
Gene expression
Genotype & phenotype
Health aspects
Hematology
Humans
Immune Checkpoint Inhibitors
Immunoregulation
Immunosuppressive cells
Immunosuppressive cellular cytokines
Immunotherapy
Leukocytes (neutrophilic)
Lymphocytes
Lymphocytes T
Macrophages
Medical prognosis
Metastasis
Neoplasms - drug therapy
Neutrophils
Oncology
Patients
Phenotypes
Review
T cells
T-Lymphocytes, Regulatory
Therapeutic applications
Therapeutic targets
Tumor cells
Tumor immune microenvironment
Tumor Microenvironment
Tumors
Vascular endothelial growth factor
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQD4gLopRHSmmNhMQBRXXiN7cWURUk4EKl3iw7tsUeml01u_z-zsTZ1UYcuHCNJ1HyjefheOYzIe8hA0-JC-TYt6YWyTe1jTzULc8m2SyRJgyrLX6o6xvx7Vbe7h31hTVhhR64AHcOqyYvhBaGhyxY0tZ3Co8mYKyLmaVCts3EdjFVfDCuCti2Rcao86HBDcEaK9fRIYMPmIWhka3_b5-8F5TmBZN7EejqGXk6pY70orzyIXmU-ufk8fdpc_yI_PyKvR7LYbMqxa1_EsXf8gNd9LRD5d5_oncJO30Xw91AfR_parnGaiF46l4fFi3V4cMLcnP15dfn63o6L6HupBXr2uRWZyOTz0o2OYrGsy6EqKWNwVjdgraCUpBNA3KN1Z2IygbeBq6k10ZI_pIc9Ms-vSY02-Q13O-9RUpAbwRHMrQUWBubyJqKfNzC51aFFsONywmjXAHbAdhuBNuZilwiwjtJpLQeL4Ci3aRo9y9FV-QM9eNKf-jOMN2FxpjKrbIV-TBKoGmCmjo_dRjAJyHJ1UzyZCYJJtXNh7dzwE0mPTjIZJRgBtLJirzbDeOdWKbWp-WmyFhwog0A9KpMmd1HI4-9lEpXRM8m0wyV-Ui_-D0SfkNAMtKY4_8B4xvypB3tQNaNOSEH6_tNegt51Tqcjib0ABMJHdw
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagSIgL4k2glCAhcUBW48RPLqitWhUk4EKlvVl27MAemiyb3f7-zjjZsBES13gSO_P0Y-YzIe9hBh5jxRFj32jKo2PUhMrTsmp0NI1AmDDMtvguL6_414VYjBtu_ZhWufOJyVGHrsY98mMIJJIXGqL559UfirdG4enqeIXGXXKPlRBsQZ_VYlpw4dqg2BXKaHncMzwWpJi_jm4ZPMEsGCXM_n89815omqdN7sWhi0fk4TiBzE8GiT8md2L7hNz_Nh6RPyU_vmDFR9dvV0OK603McXO-z5dtXqOI15_y64j1vsv-us9dG_JVt8GcIfjqXjVWPuSI98_I1cX5z7NLOt6aQGth-IbqplSNFtE1UrAmcOaK2vughAleG1WCzLyUMKeuQ8OMqnmQxlelr6RwSnNRPScHbdfGlyRvTHQK3nfOIDCg07xCSLToizKwULCMfNyxz64GcAybFhVa2oHZFphtE7OtzsgpcniiRGDr9KBb_7KjnVhYJDvoiuvKN9CTMq6WeBNFUcBwiygz8hblY4cq0ck87YnCyFoZaTLyIVGggYKYajfWGcAvIdTVjPJwRgmGVc-bdzpgR8Pu7V81zMi7qRnfxGS1NnbbgcaAK2XAoBeDykw_jWj2QkiVETVTphlX5i3t8neC_YawpIXWr_4_rNfkQZk0XFCmD8nBZr2Nb2DetPFHyThuAXHNFjA
  priority: 102
  providerName: ProQuest
– databaseName: Scholars Portal Journals: Open Access
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3di9QwEA_nCeKL-G3PUysIPki1-U4EkVM8TuH0xYV7C0mbngteu7fdFf3vnekXW7wHX5tJ2kxmMjPNzC-EvAAPPEYuEGPfmkxETzNb8pAxXploK4kwYZht8VWdLMSXM3m2R8brjgYGtleGdnif1GL98_Xvyz_vQeHfdQpv1JuW4nFfhnnpuN2Chl8j15ngDFP8TsV0qoCxQl8gKRXsAoyNRTRXjjEzVB2e_7-79o7ZmqdU7tio49vk1uBcpke9NNwhe7G-S26cDsfn98i3z1gN0rTbVZ_--ium-OO-TZd1WuDyr9-mFxFrgZftRZv6ukxXzQbziWDUnUqttM8fb--TxfGn7x9PsuFGhayQVmwyUzFdGRl9pSStSkF9XoRQamnLYKxmsJ5BKfC3i7KiVheiVDZwFriSXhsh-QOyXzd1fETSykavob_3FkEDvREc4dJiyFlJy5wm5NXIPrfqgTNcF3AY5XpmO2C265jtTEI-IIcnSgS97h4063M36JCDANrDq4ThoYI3aesLhbdU5Dl8bh5VQp7h-ri-gnRSXXek0epyq2xCXnYUKE6wTIUfahBgSgiDNaM8nFGC0hXz5lEG3CizDnwdJXIDDmdCnk_N2BMT2erYbHsaC9ssBQY97EVmmjQi3UupdEL0TJhmXJm31MsfHSQ4mCwjjTn47_k9JjdZJ-wyo-aQ7G_W2_gE3KtNeNrpzF9VXx9V
  priority: 102
  providerName: Scholars Portal
Title Immunosuppressive cells in cancer: mechanisms and potential therapeutic targets
URI https://www.ncbi.nlm.nih.gov/pubmed/35585567
https://www.proquest.com/docview/2666408929
https://search.proquest.com/docview/2666907011
https://pubmed.ncbi.nlm.nih.gov/PMC9118588
https://doaj.org/article/274a447483bf40e79ac6103100cdf0e6
Volume 15
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwED9tQ5r2gvgmMEqQkHhA2fJhOzZv3bRpVOqYgEl9s-zEgUo0rZqWv587JymNeOOlkepzPs73s--S350B3qMH7lzGqMa-khFzJolUmdkozSrpVMWpTBixLW7FzT2bzPjsAHifC-NJ-4Wdn9W_Fmf1_KfnVq4WxXnPEzu_m14iQCXHyO0QDtE37EP0dvqlgCDus2OkOG8S-hYYEWmd5mKE_wkcU01xzv3e8n8XI1-z_9-ZeW9pGtIm99ah60fwsHMgw3F7o4_hwNVP4HjafSJ_Cl8-U8bHstmuWorrbxfSy_kmnNdhQUO8_hQuHOX7zptFE5q6DFfLDXGG8Kx72VhhyxFvnsH99dX3y5uo2zUhKrhim0hWaV5J7kwleFKVLDFxYW2Zc1VaqfIUx8wKgXoryipRecFKoWyW2kxwk0vGs-dwVC9r9xLCSjmTY39jFBUGNJJlVBLN2TgtkzJOAvjYq0-v2uIY2gcVUuhW7xr1rr3etQzggjS8k6TC1v6P5fqH7oZXY5Bs8FJMZrbCK-XKFIJ2oohjvN3YiQDe0vjoNkt0B089zmllzZRQAXzwEgRQHKbCdHkG-EhU6mogeTqQRGAVw-beBnQH7EajPyNYLNGpDODdrpl6ElmtdsttK6NwKk1QQS9ak9k9dG95AeQDYxpoZdiCKPBlvzurf_XfPV_DSepxwKNEnsLRZr11b9Cl2tgRAmmWj-DBeDz5NsHjxdXt3deRf0GBv1MmRx5kfwDv7SUW
link.rule.ids 230,315,729,782,786,866,887,2104,12063,21395,24325,27931,27932,31726,31727,33751,33752,43317,43812,53798,53800
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwEB5BkYAL4k2g0CAhcUBR8_CTCyqIagttubTS3iw7dsoemmw3u_39zCTZsBES13jymqfHnvkM8AFn4CEUjDD2tUpYsFmifeGSvKhU0BUnmDCqtjgXs0v2Y87nw4JbO5RVbn1i56h9U9Ia-SEGEsFShdH8y_ImoVOjaHd1OELjLtyjzh9KvuR8TLgoN0i3jTJKHLYZbQsmVL9Obhk9wSQYdZj9_3rmndA0LZvciUPHj-HRMIGMj3qJP4E7oX4K98-GLfJn8OuEOj6adrPsS1xvQ0yL8228qOOSRLz6HF8H6vddtNdtbGsfL5s11QzhU3e6seK-Rrx9DpfH3y--zZLh1ISk5JqtE1XlslI82ErwrPIss2npnJdce6e0zFFmTgicU5e-yrQsmRfaFbkrBLdSMV68gL26qcMriCsdrMT7rdUEDGgVKwgSLbg095lPswg-bdlnlj04humSCiVMz2yDzDYds42K4CtxeKQkYOvuQrO6MoOdGEySLb6KqcJV-CapbSnoJIo0xc9Ng4jggORj-i7R0TzNkaTIWmihI_jYUZCBophKO_QZ4C8R1NWEcn9CiYZVToe3OmAGw27NXzWM4P04THdSsVodmk1Po9GVZsigl73KjD9NaPacCxmBnCjThCvTkXrxu4P9xrCkuFKv__9ZB_BgdnF2ak5Pzn--gYd5p-08ydQ-7K1Xm_AW51Br964zlD-w9hkg
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELagSKteUHk2UGiQkDigdJ2HHZtbKaxaoKUHKvVm-RVYic1Gm93-fmacZNmIG9e1vUnm5Znkm8-EvIUM3Pu8QI59KZLC6zSRLjdJllfCy4ohTRiiLa74-U3x5Zbd7hz1FUD71sxP6t-Lk3r-K2Arm4WdDjix6fXlGTioYFC5Na6a3icPwGcpHQr1LghjWUCHHhnBp22KXwQThK5jRIYgsE8myCzOWDhh_u-WFJj7_43POxvUGDy5sxvNDsjDPo2MT7vbfUTu-foxmVz2H8qfkO8X2PexbDdNB3S98zG-om_jeR1bVPTqQ7zw2PU7bxdtrGsXN8s1IofgX3d6suIOKd4-JTezzz_OzpP-7ITEMlmsE1FlZSWY1xVnaeWKVFNrjCuZdEbIMgPNGc4hs7auSmVpC8elyTOTc6ZLUbD8Gdmrl7U_JHElvS5hvdYS6QG1KHIkRvOGZi51NI3I-0F8qukoMlQoLQRXndwVyF0FuSsRkY8o4e1MpLcOPyxXP1WvZAWlsoZLFSI3FVyplNpyPI-CUrhd6nlEjlE_qusV3TqpOi1xf80llxF5F2agm4KarO67DeCRkPBqNPNoNBPcy46HBxtQvXu3CrIaXlABqWVE3myHcSVC1mq_3HRzJATUFAT0vDOZ7UMPlheRcmRMI6mMR8AXAvl3b_sv_nvlMZlcf5qpbxdXX1-S_Sy4BEtScUT21quNfwU51tq8Dt70B50UI5U
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Immunosuppressive+cells+in+cancer%3A+mechanisms+and+potential+therapeutic+targets&rft.jtitle=Journal+of+hematology+and+oncology&rft.au=Tie%2C+Yan&rft.au=Tang%2C+Fan&rft.au=Wei%2C+Yu-quan&rft.au=Wei%2C+Xia-wei&rft.date=2022-05-18&rft.pub=BioMed+Central+Ltd&rft.issn=1756-8722&rft.eissn=1756-8722&rft.volume=15&rft.issue=1&rft_id=info:doi/10.1186%2Fs13045-022-01282-8&rft.externalDocID=A704293969
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1756-8722&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1756-8722&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1756-8722&client=summon